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Abstract 
Engineering Electron Transfer Processes in Oxidoreductases: 
Applications in Biocatalysis 
 
Harun Ferit Ozbakir 
 
As the demand for cost-efficient and environmentally friendly processes increases in the 
chemical industry, impact of biocatalysis, which is the utilization of enzymes and whole 
microorganisms for production of fine chemicals, has become more predominant. From 
pharmaceuticals to cosmetics, biocatalysts are widely used in various sectors, and their 
significance have dramatically intensified with the introduction of initial protein 
engineering techniques in 1980s. As the field of protein engineering has evolved over the 
last few decades, its integration with other disciplines such as process engineering and 
synthetic biology is now more critical for establishing non-natural pathways and 
reactions to produce broader range of chemicals. While developing an interdisciplinary 
approach, few strategies have emerged to be more prevalent: (i) better integration of 
biocatalysts with (nano)devices, and (ii) use of protein based scaffolds for creating novel 
synthetic multienzyme cascades. 
 
Throughout this doctoral thesis, applicability of these ideas with oxidoreductases was 
investigated. Oxidoreductases are a class of under-utilized enzymes that catalyze the 
electron transfer between different metabolites, while at the same time use cofactors 
(NAD(P)(H), molecular oxygen, etc.) as the electron supplier. In Chapter 2, the electron 
transfer mechanism of a monooxygenase, cytochrome P450 27B1 (CYP27B1), was 
mimicked for electrochemical sensing of a vitamin D form (25(OH)D) in solution. 
Natural electron transfer pathway of this enzyme uses NADPH and two electron transfer 
proteins for conversion of 25(OH)D to its product. Inspired by this mechanism, this 
enzyme was mixed with an artificial redox mediator and immobilized on an electrode 
surface. As a result of rigorous experiments, CYP27B1-modified electrode was found to 
detect 25(OH)D in its physiological range. This is a significant result as it opens a new 
way for development of a vitamin D biosensor that can diminish the amount of required 
cost and time for testing. 
 
In the next chapter of the thesis, effects of changing the size of cofactor on catalysis of 
dehydrogenases were studied in detail. Natural cofactors of two different redox enzymes 
were chemically modified with PEG, and kinetic experiments were conducted in order to 
better understand the relation between transport phenomena and biocatalysis. It was 
found that when the size of the cofactor was increased, two enzymes were affected 
differently; while efficiency of one enzyme was not altered significantly, that of the other 
dropped dramatically. Through comprehensive analysis, dominant impact of PEGylation 
was determined to be due to the differences in the interactions of PEGylated cofactors 
and enzymes. This study showed that protein engineering methods can be utilized to gain 
insights into better understanding of the relationship between mass transfer and catalysis 
in engineered bioprocesses and biocatalytic cascades. 
In Chapter 4, PEGylated cofactors were used to create artificial multienzyme complexes. 
In this study, SpyCatcher-SpyTag scaffold was utilized for wiring two redox enzymes 
and by tethering with PEGylated cofactors, a new biocatalyst with self-contained redox 
chemistry was obtained. Detailed kinetic analysis showed that this new multienzyme 
cascade was able to catalyze a reaction that was thermodynamically downhill but 
kinetically very slow in the absence of any enzyme. This also proved that attached 
cofactor acts as a ‘swing-arm’, carrying electrons from one enzyme to another; similar to 
the unique mechanism of pyruvate dehydrogenase complex. Generality of this 
methodology was investigated by constructing an immobilized three-enzyme-containing 
biocatalyst, which was hypothesized to catalyze an industrially important reaction under 
very mild conditions. This work is a significant contribution to the field, and a good 
demonstration of use of protein engineering for process engineering applications. 
 
Chapter 5 concludes this thesis with a study that investigates the practicability of a 
collagen mimetic peptide as a novel way of constructing multiprotein cascades. Collagen 
mimetic peptides are composed of three individual strands that might (homotrimer) or 
might not (heterotrimer) have identical sequences, and in this work, we have utilized a 
recently designed hydroxyproline-free sequences of a heterotrimer collagen mimetic 
peptide. Individual strands were attached to different proteins by genetic fusion, and 
optimum experimental conditions for self-assembly of a multiprotein complex were 
investigated. Initial results suggested formation of such a complex, but further 
experiments are required to finalize the confirmation. This new collagen-based platform 
studied in this chapter is a crucial step towards development of cofactorless multienzyme 
cascades.  
 
Finally, this doctoral thesis demonstrates the prominence of protein engineering in 
biocatalysis applications by utilizing various strategies together with the electron transfer 
mechanisms of oxidoreductases. By expanding and building upon these methodologies, it 
is possible to obtain more improved biosensors and functional artificial multienzyme 
cascades with industrial applications. Hence, this study is a promising example to exhibit 
the impact of interdisciplinary approach on industrial biotechnology. 
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1.1. Biocatalysis 
 
One of the most important areas in chemical engineering and chemistry is catalysis. As 
catalysis is being used widely for production of fine chemicals in a wide variety of 
industries, its influence on economy is inevitable. Furthermore, an interdisciplinary 
approach is quite significant for development of environmentally friendly or green 
processes while at the same time keeping the cost of these processes at optimum levels 
(1-3).  
 
Over the last few decades, there has been an increasing interest to biocatalysis, despite 
the fact that homogeneous and heterogeneous catalysis are still commonly preferred 
approaches that are utilized in chemical industry (1). However, recent developments in 
recombinant DNA technologies and excellent properties, such as turnover rates and 
selectivities, of biocatalysts have made wider use of them more plausible (1). Figure 1.1 
shows the sectors where biocatalytic reactions are utilized for production of fine 
chemicals (2). 
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Figure 1.1. Industrial sectors where biocatalysts are commonly utilized. (2) 
 
The evolution of biocatalysts has been speculated to happen through three waves (4-7). 
The first wave started in early 1900s, where whole cells or parts of living cells were used 
for chemical transformations (7). The limited stability of these biocatalysts was the main 
issue in these kinds of transformations; however, immobilization of enzymes was a 
helpful approach to increase the lifetime of such catalysts. Moreover, the use of whole 
cells for chemical transformations is advantageous due to the ease of cofactor 
regeneration, but separation of any undesired side products and any restrictions imposed 
by the cell membrane are major drawbacks (4, 7). Introduction of recombinant DNA 
technology and other protein engineering techniques in 1980s (the second wave of 
biocatalysis) made it possible to produce enzymes much cheaper (7). In addition, these 
methods expanded the substrate range of enzymes, which, in turn, enabled products with 
atypical properties, but further research was required in order to optimize the enzymes for 
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these unusual reactants (8). The third wave, starting in mid-to-late 1990s, was possible 
with advanced protein engineering methods such as directed evolution, bioinformatics, 
cheaper gene synthesis and sequencing; and has allowed production of enzymes with 
improved stability, specificity and stability (7, 9). With advances in biocatalysis, in 
addition to synthetic biology and metabolic engineering, it is now much easier to develop 
new biocatalysts for a desired end product. 
 
1.2. Advantages of Enzymes 
 
There are still few barriers that need to be overcome before utilizing them for 
applications in an industrial scale. One important obstacle is the required amounts of 
substrates and products on a bioreactor. Chemical processes, in general, require molar 
concentrations of chemicals for operation; however, these amounts are mostly inhibitory 
for the enzyme of interest (10, 11). Another barrier is the properties of substrates and 
products, such as stability and solubility. These properties might necessitate physical 
conditions that may not be feasible for optimum operation of the biocatalyst (11). 
Requirement of stoichiometric amounts of cofactors is another problem, but this might be 
overcome by cofactor regeneration using various electrochemical, chemical, and 
enzymatic methods (11).  
 
In spite of all these problems, there are few advantages of enzymes that make them 
desirable for industrial applications (2, 11): 
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• Enzymes use water as a solvent and catalyze effectively in water. This could be 
considered as a green alternative to most industrial catalysts, which generally use 
organic solvents (2, 11). 
• Most enzymes work very efficiently under mild conditions such as room 
temperature/pressure and near neutral pH, whereas chemical catalysts might 
require more harsh conditions (2, 4). 
• Enzymes catalyze reactions with extreme chemical selectivity, which is critical 
for production of specific chemicals, and reduce any efforts for separation of 
undesired side products (7, 11). 
• Enzymes can use variety of substrates, and this range can be expanded by protein 




Although an increasing number of enzymes are being utilized as a part of industrial 
bioreactors, oxidoreductases are still not widely used (2, 12). Oxidoreductases are the 
class of enzymes that catalyze electron transfer from one metabolite to another, usually 
with the help of the cofactor NAD(P)(H) (4, 13): 
 𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒   𝑟𝑒𝑑 +   𝑁𝐴𝐷(𝑃)! ↔   𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒   𝑜𝑥𝑑 +   𝑁𝐴𝐷 𝑃 𝐻 + 𝐻! 
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Cytochrome, molecular oxygen, hydrogen peroxide, disulfides, and flavin are also used 
as cofactors by oxidoreductases. Approximately 45% of all known enzyme reactions are 
identified to use at lease one cofactor (14). Dehydrogenases, monooxygenases, 
dioxygeneases, oxidases, and peroxidases are some of the subclasses of oxidoreductases. 
Enzymes used in this Thesis fall into two subcategories; monoxygenases (Chapter 2) or 
dehydrogenases (Chapters 3-5). 
 
1.3.1. Cytochromes P450 and CYP27B1 
 
Cytochromes P450 are one of the largest heme-thiolate enzyme families that have over 
7000 members in bacteria, plants and mammals (15). The name P450 does not come from 
its function, instead this type of enzymes show a unique absorbance band at 450 nm when 
they are bound to carbon monoxide (16). There is a cysteine molecule in the heme 
domain, and it is an important thiol ligand for the heme iron, this makes these enzymes 
heme-thiolate proteins rather than cytochromes. Moreover, cytochromes are generally 
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Figure 1.2. Cytochromes P450 in enzymes (shown in dark grey) (16) 
 
Based on their arrangement of heme and reductase domains and requirement of redox 
partner, P450s can be grouped into different classes (17). These enzymes have different 
functions in human body, and they are associated with biosynthesis of steroids, vitamins 
and lipids, xenobiotic and drug metabolism (15, 17). Their ability of oxidation of various 
substrates makes P450s valuable tools for development of biosensors and bioreactors in 
different industries. Protein engineering studies have been extensively used for their 
functional immobilization for the development of electrochemical biosensors (15).  
 
Cytochrome P450 27B1 (CYP27B1) is the responsible enzyme for the hydroxylation of 
25(OH)D to 1,25(OH)2D and is a mitochondrial type of P450. Like most of the P450s, 
CYP27B1 uses NADPH as a cofactor for the addition of oxygen to the substrate 
25(OH)D. The reaction is shown below: 25 𝑂𝐻 𝐷 + 𝑂! + 2𝐻! + 2𝑒! → 1,25(𝑂𝐻)! + 𝐻!𝑂 
Two electrons necessary for this reaction that comes from NADPH is transferred using a 
redox partner. In humans, these transfer proteins are adrenodoxin, which contains a [2Fe-
2S] region that acts as the electron transfer center, and adrenodoxin NADP+ reductase, 
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which is a flavin adenine dinucleotide (FAD) containing enzyme (15). FAD region is the 
redox center of this enzyme; therefore it is the electron transfer region.   
 
In Figure 1.3(A), crystal structure of CYP27B1 is shown. Solved X-ray structures of 
different P450s are observed to have a similar conserved fold (15). Although most P450s 
share similar secondary structures, it is observed that there are certain differences among 
them, specifically in regions related to substrate binding. In addition, the topology of 
P450s is arranged in a way that eases the interactions between redox proteins (such as 
adrenodoxin reductase) and cytochrome P450s (18).   
 
 
Figure 1.3. Cytochrome P450 27B1 structure and mechanism. (A) Crystal structure of 
CYP27B1; (B) Cytochromes P450 catalytic cycle (15) 
 
The cytochrome P450 catalytic cycle (which is the same for all P450s) is shown in Figure 
1.3(B). For CYP27B1, substrate RH is 25(OH)D and the product ROH is 1,25(OH)2D. 
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The first step in this cycle is the binding of the substrate RH. A water molecule is 
released upon binding of the substrate, which changes the spin state of ferric Fe3+ iron 
from low to a high one. Following this step, first electron transfer to iron is supplied from 
adrenodoxin, which reduces the ferric ion to Fe2+. Molecular oxygen binds to this form 
and di-oxygen complex is formed. After the second electron transfer, peroxo form and 
with the addition of H+, hydroperoxo form is produced. Further protonation of this form 
yields the reactive intermediate, which can easily donate its oxygen to substrate, forming 
the desired product, in this case, 1,25(OH)2D (19). As seen in the catalytic cycle, electron 
requirement of these systems makes them valuable tools for development of 




Compared to the complex reaction pathway of cytochromes P450 detailed in the previous 
section, dehydrogenases used in this study have a much simpler electron transfer 
mechanism. Five different dehydrogenases have been utilized in this Thesis, formate 
dehydrogenase (Chapters 3-5), lactate dehydrogenase (Chapters 3 and 5), malate 
dehydrogenase (Chapter 4), aldehyde dehydrogenase (Chapter 4), and alcohol 
dehydrogenase (Chapter 4). They all follow the reaction that was outlined at the 
introduction of Section 1.3, and all of them use NAD(H) as the cofactor. 
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Formate dehydrogenase (FDH) used in this work is a dimeric protein from S. cerevisiae. 
This enzyme oxidizes formate to CO2 while reducing NAD+ to NADH (20, 21). Its 
crystal structure has not been solved, however, homology models can be used to predict 
an estimated structure (Figure 1.4(A)). FDH was selected because it has been used for 
cofactor regeneration extensively (21), its substrate formate is inexpensive, and its 




Figure 1.4. Crystal structures of (A) formate dehydrogenase (based on a homology 
model) and (B) lactate dehydrogenase.  
 
Lactate dehydrogenase catalyzes the reversible reduction of pyruvate to D-lactate, and its 
substrate pyruvate is a central node in biological pathways. There are several versions of 
this enzyme, with E. coli having two different kinds (22). One is NAD(H)-independent 
(iLDH) and contains a FAD cofactor, tightly bound to the enzyme. The version that was 
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utilized in this Thesis is NAD(H)-dependent (nLDH), a tetrameric enzyme that does not 
contain any attached cofactor. Its crystal structure has recently been solved (23) and can 
be seen in Figure 1.4(B).  
 
Other three dehydrogenases used in Chapter 4 were from different sources. Porcine heart 
cytosolic malate dehydrogenase (cMDH) is a dimeric enzyme responsible for reversible 
conversion of oxaloacetate to malate (24). Human aldehyde dehydrogenase (ALDH) is a 
tetrameric enzyme with reversible conversion of formaldehyde to formate (25). Finally, 
B. stearothermophilus alcohol dehydrogenase (ADH) is a tetrameric enzyme with 
reversible conversion of formaldehyde to methanol (26). 
 
1.4. Research Objectives 
 
As biocatalysis has advanced from a traditional approach, where natural reactions and 
pathways are the only way to produce desired chemicals, towards a multistep/engineered 
approach, where combination of non-natural pathways and reactions are utilized for a 
broader range of chemicals, integration of protein engineering with other disciplines 
(such as process engineering) has become more crucial. When designing new pathways 
and solutions for the future by utilizing an interdisciplinary approach, few ideas will 
result in better results imminently.  
 
	   12	  
One such idea is integration of biocatalysts with (nano)devices (7, 27). Enzyme 
immobilization is an approach that has been widely used since the first wave biocatalysis. 
However, by playing with the orientation of enzymes on surfaces and by mimicking the 
electron transfer mechanisms of enzymes, it might be possible to obtain more effective 
enzyme immobilization strategies with better efficiencies. 
 
Another recently popular idea is the use of DNA and/or protein based scaffolds to create 
previously non-existing multienzyme complexes (7, 28, 29). It is possible to design a 
variety of these cascades by controlling the geometry and/or organization of individual 
parts, and therefore, create new pathways that have not been possible with traditional 
enzyme engineering techniques before. As a result, excessive cofactor requirement of 
dehydrogenases (for electron transfer processes) might be significantly reduced or 
theoretically may be eliminated. These approaches will substantially improve the 
efficiencies, and become more crucial in chemical synthesis. 
 
In this Thesis, these aforementioned ideas and the electron transfer mechanisms of 
oxidoreductases have been integrated for use in various applications of biocatalysis. In 
Chapter 2, utilization/mimicking of electron transfer mechanism of a mitochondrial 
cytochrome P450 for detection purposes is discussed. In this work, this specific enzyme 
is used in combination with an artificial redox mediator and immobilized on an electrode 
surface and this enzyme mobilized electrode is sensitive to 25(OH)D (most circulating 
form of vitamin D) in the physiological range. This study is a proof-of-concept which 
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demonstrates the possibility of a biosensor that would decrease the amount of time and 
cost required for testing vitamin D levels (30). 
 
Chapters 3, 4, and 5 of this study focus on understanding and engineering of electron 
transfer mechanisms of dehydrogenases for construction of improved multienzyme 
complexes. In Chapter 3, we have chemically modified (increase the size by PEGylation) 
the natural cofactor of two redox enzymes, and systematically study the effect of this 
modification on enzymatic activity, with emphasis on the relationship between 
biocatalysis and transport phenomena. We find that upon the PEGylation of cofactor, 
mass transfer to the enzyme is not a rate-limiting step in biocatalysis for either enzyme. 
As the PEGylation affects the rate of formation of enzyme/cofactor complexes and/or the 
formation of enzyme/cofactor/substrate complexes, we hypothesize that the dominant 
effect of PEGylation is related to altered interactions between the enzyme and modified 
cofactors (31). 
 
Building upon our improved understanding of modified cofactors, Chapter 4 focuses on 
creating functional artificial multienzyme complexes with cofactor swing arms. Firstly, 
by using a robust SpyCatcher-SpyTag staple (32), we bring two redox enzymes in close 
proximity, and further modify this cascade with tethered PEGylated cofactors (or cofactor 
swing arms). We show the functionality of this complex, which means the attached 
cofactor acts as a swing-arm, then study its kinetics and compare to individual enzymes. 
Following this, we study the generality of this approach, by creating an immobilized 
	   14	  
three-enzyme system; and we hypothesize this to be a crucial and industrially relevant 
biocatalyst with novel properties. The methodology here is a showcase to demonstrate the 
importance of integrated use of protein engineering with other disciplines. 
 
Finally, in Chapter 5, we test the feasibility of using a collagen mimetic peptide as a new 
way of creating artificial multiprotein complexes. For this purpose, sequences of a 
recently published collagen heterotrimer is utilized (33) and two of the individual strands 
is genetically fused to two different proteins; one being a redox enzyme, and the other 
being green fluorescent protein. By systematically testing various experimental 
conditions, we hypothesize that we find the optimum temperature for collagen formation 
reactions, where we analyze various mixtures with size exclusion columns. Upon further 
experimental confirmation of a multiprotein complex, brought together with a collagen 
mimetic peptide for the first time, this new platform will create a path towards more 
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CHAPTER 2 
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A version of this chapter, titled as “Detection of 25-Hydroxyvitamin D with an Enzyme 
Modified Electrode”, is published in Journal of Biosensors and Bioelectronics (2016) 
7:193, with co-authors David A. Sambade, Sudipta Majumdar, Linda A Linday, Scott 




Since testing for circulating vitamin D concentrations is relatively expensive and time 
consuming, rapid means of measurement are desired. As a step towards this goal, 
enzyme-modified electrodes responsive to 25-hydroxyvitamin D3 (25(OH)D3) have been 
developed.  To make the enzyme, a synthetic gene encoding a human cytochrome P450 
27B1 (CYP27B1) enzyme, which is a mitochondrial type heme-thiolate monooxygenase 
that converts 25(OH)D3 into 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), was expressed 
and purified.  The CYP27B1 enzyme was combined with NADPH-adrenodoxin reductase 
(ADR) and adrenodoxin (ADX) and activity was characterized using liquid 
chromatography mass spectrometry (LC-MS/MS). It was found that dihydroxyvitamin D3 
isomers were produced in addition to 1,25(OH)2D3. The enzyme was immobilized on 
glassy carbon electrodes using pH-adjusted Nafion® along with cobalt sepulchrate 
trichloride (Co(sep)3+) as a redox mediator and electrode performance was characterized 
using cyclic and square wave voltammetry. The results demonstrate detection of 
25(OH)D3 in buffer within the physiological range (5-200 ng/ml). 
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2.2 Introduction 
 
The cytochromes P450 (CYP450) are a super family of heme-thiolate monooxygenases 
and can be found in organisms from various domains of life (1-2). These enzymes are 
capable of metabolizing a diverse range of chemicals using different biotransformation 
reactions and are associated with biosynthesis of steroids, vitamins and lipids, xenobiotic 
and drug metabolism (1-8). Thus, there has been immense biotechnological interest in 
these enzymes, and they have been utilized for applications in bioelectronic devices, 
biochips, bioreactors, and biosensor technologies (9-12).  
 
The catalytic mechanism of the enzymatic CYP450 reaction involves several steps (13-
15). The two electrons necessary for the catalytic cycle are supplied by the electron donor 
NADPH and transferred via two electron-transfer proteins, NADPH-adrenodoxin 
reductase (ADR) and adrenodoxin (ADX) (7). This pathway could potentially be utilized 
using electrochemical methods to detect NADPH/NADP+ redox couple on an electrode 
(Fig 2.1(A)) (16-18). As an alternative, non-native redox mediators can be used for 
electron delivery and electrochemical quantification of enzymatic activity (Fig 2.1(B)). 
Another alternative is direct electron transfer, where the enzyme can be deposited on the 
electrode by itself, can be attached to the electrode via gold nanoparticles (19), or can be 
immobilized to the electrode that is modified with polyelectrolyte multilayer films (20). 
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In vivo, the cytochrome P450 27B1 (CYP27B1) enzyme, which is a mitochondrial type 
CYP450, converts 25-hydroxyvitamin D (25(OH)D) into 1,25-dihydroxyvitamin D 
(1,25(OH)2D). 25(OH)D is considered the best indicator of the body’s vitamin D status 
(21). Vitamin D is crucial for the human body due to its role in calcium and bone 
metabolism (21- 22).  The best-known effect of vitamin D is the prevention of bone 
disease; vitamin D prevents rickets in growing children and osteomalacia (soft bones) in 
adults. Recent research has linked vitamin D to health benefits across the human lifespan. 
Recent data suggest vitamin D may reduce the risk of cancers, heart disease, autoimmune 
diseases, and type-2 diabetes (23). In addition, low vitamin D levels have been linked to 
neuropsychiatric disorders, such as depression (24), Parkinson’s disease (25), and 
Alzheimer’s disease (26).  
 
Vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol) are the two common forms 
of this nutrient.  Detection of vitamin D deficiency is generally accomplished using 
commercial assays for 25(OH)D. Radioimmunoassays (RIA), high pressure liquid 
chromatography (HPLC) and liquid chromatography mass spectrometry (LC-MS/MS) are 
used for determining 25(OH)D2 and 25(OH)D3 values in serum (21). These blood tests 
are performed in centralized laboratories; they are also expensive, and the results are 
delayed. In addition, two or three blood tests obtained over the course of several months 
may be necessary to indicate proper treatment. Another problem that should be addressed 
when analyzing the blood samples is the presence of 1,25(OH)2D as the inhibitory effects 
of this product on level of 25(OH)D is not known (27-29). 
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Moreover, vitamin D supplementation has become a controversial topic. Many vitamin D 
experts disagree with the Institute of Medicine (IOM) recommendations regarding the 
amount of vitamin D for daily supplementation, as well as with the blood levels the IOM 
considers optimal (30). Since measurement of 25(OH)D is relatively costly, blood level 
measurements are only recommended for people at known risk of vitamin D deficiency 
(23); however many experts believe that asymptomatic vitamin D deficiency is 
widespread and a larger patient population should be tested for their vitamin D levels. 
The availability of a quick and inexpensive 25(OH)D blood measurement may allow for 
optimization and individualization of vitamin D supplementation. 
 
CYP27B1, which catalyzes hydroxylation at the 1α-position of 25(OH)D, has been 
cloned from several species including rats, mice, and humans with generally low 
expression levels and poor stability (31-33). The human CYP27B1, a 55 kDa 
hemoprotein (27), is membrane associated, and has been cloned and expressed 
recombinantly in E. coli by several groups (28, 34-38). It has also been observed that 
recombinant CYP27B1 is active with other vitamin D isoforms (such as vitamin D3 and 
24,25(OH)2D3) when reconstituted in bacterial expression systems (34-36). Various 
strategies have been used to optimize and increase the expression levels of CYP27B1 
protein in E. coli including co-expression with molecular chaperones GroEL/ES (28, 34). 
The CYP27B1 enzyme cloned from the mouse kidney has been investigated, including at 
least one electrochemical study (39).  In the previous study, a surfactant material was 
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used to solubilize and immobilize the enzyme, permitting electrochemical 
communication between the heme group of the enzyme and electrode.  However this led 
to deleterious impact on catalytic activity.  We have explored alternative approaches. 
 
Cobalt sepulchrate trichloride (Co(sep)3+), a non-native redox mediator, has been 
effectively utilized with other CYP450s (40-42). Faulkner et al. reported that Co(sep)3+ 
can be used in a CYP4A1 system with rates comparable to those obtained with NADPH 
(26). Another research group constructed a biosensor by immobilizing CYP3A4 and 
Co(sep)3+ on a Nafion®-modified electrode and reported relevant detection limits for the 
substrate of CYP3A4 (41). Synthetic mediators like Co(sep)3+ have multiple advantages 
such as facilitating quick, reversible electrochemistry, enhanced rates of reactions, and 
facile electrode design while maintaining flexibility in enzyme immobilization (43).   
 
In the present work, we developed an enzymatic electrode for 25(OH)D3 detection in 
buffer, because testing for circulating 25(OH)D3 takes significant amount of time and is 
costly. As a first step, a synthetic gene encoding the human CYP27B1 was expressed in 
E.coli, purified, and its activity was identified using LC-MS/MS.  The redox mediator 
Co(sep)3+ was synthesized and utilized for electrochemical detection of CYP27B1 
activity (Fig 2.1(B)). For this purpose, the mixture of purified CYP27B1, the redox 
mediator Co(sep)3+, and Nafion® were immobilized on the glassy carbon electrode, and 
performance of the electrode was characterized in the physiological range of 25(OH)D3 
using cyclic and square wave voltammetry.   
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NADPH, 3-((3-cholamidopropyl)dimethylamino)-1-propanesulfonate (CHAPS), lithium 
carbonate, sodium diethyldithiocarbamate trihydrate, hexane, dichloromethane, Nafion®-
117 solution, and 25(OH)D3 were obtained from Sigma Aldrich (St. Louis, MO, USA). 
Tris(ethylenediamine) cobalt(III) chloride trihydrate was obtained from Alfa Aesar. Anti-
CYP27B1, anti-adrenodoxin and anti-adrenodoxin reductase primary antibodies and 
FITC-conjugated secondary antibodies were obtained from Abcam. A HisTrapTM HP 
column was obtained from GE Healthcare. Glassy carbon working electrode (model MF-
2012) and Ag/AgCl reference electrode (model MF-2052) were obtained from BASi Inc. 
 
2.3.2. Cloning, Expression and Purification of Proteins 
 
A gene encoding the human CYP27B1 gene with a C-terminal myc-tag and a 6x His-tag 
was codon optimized for E. coli expression and chemically synthesized by DNA2.0 
(DNA2.0, CA, USA).  The N-terminal 32 amino acids of the 521 amino acid protein have 
been shown to constitute a pre-sequence, which targets the enzyme to the inner 
mitochondrial membrane and is cleaved to give the 489 amino acid mature protein (44). 
Therefore, the first 31 amino acids were removed and Ser32 was mutated to Met32 by 
PCR to enable E. coli expression of the mature protein.  The CYP27B1 gene was PCR-
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amplified using primers pr1 and pr2 (Table S2.1 in Supporting Information) producing 
5’-NdeI and 3’-EcoRI restriction sites, respectively.  The amplified PCR product was 
ligated into pre-digested pET20b vector, creating the plasmid pCYP. 
 
Human ADX and ADR genes were PCR amplified from the pTC27A1 plasmid with C-
terminal 6x His-tag using pr3 and pr4 for ADX, and pr5 and pr4 for ADR (Table S2.1 in 
Supporting Information) having 5’-NdeI and 3’-EcoRI restriction sites (45). The 
amplified PCR products were ligated separately into pre-digested pMAL-c4E vector 
using the In-Fusion HD cloning kit (Clontech, USA). The plasmids containing ADX and 
ADR were named pAdx and pAdr, respectively. 
 
All three plasmids pCYP, pAdx and pAdr were transformed into E. coli BL21 cells 
containing pGro7 plasmid which encodes chaperons GroEL/ES (34). A single colony was 
used to inoculate 5 mL of TB broth containing 100 µg/mL ampicillin and 35 µg/mL 
chloramphenicol and incubated overnight at 37 ͦC with shaking. The overnight cultures 
were added to 1 L TB broth containing the same antibiotics and incubated at 37 ͦC 
shaking at 200 rpm until the cell density (OD600) reached about 0.6. At this point, the 
transcriptions under the t7 (CYP27B1), tac (ADX and ADR), and araB (GroEL/ES) 
promoters were induced by IPTG and arabinose at a final concentration of 0.5 mM and 
200 µg/mL, respectively. δ-Aminolevulinic acid (ALA) was also supplemented to a final 
concentration of 1.0 mM. The cultures were shaken at 28 °C for 20 h and cells were 
harvested by centrifugation. The cell pellets were resuspended in 50 mL of buffer 
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containing 100 mM Tris-HCl, 200 mM NaCl, 0.1 mM EDTA, 0.1 mM DTT, 0.1 mM 
PMSF, 1% CHAPS (w/v) and 20% glycerol (v/v) (pH 7.4). The suspension was sonicated 
to lyse the cells, and cleared by centrifugation. The supernatant was applied to a 5 mL 
HisTrapTM HP column (GE Healthcare) and eluted with a linear gradient (50 mL) of 0 to 
100 mM imidazole containing 100 mM Tris-HCl, 200 mM NaCl, 0.1 mM EDTA, 0.1 
mM DTT, 0.1 mM PMSF, 1% CHAPS (w/v) and 20% glycerol (v/v) (pH 7.4). Fractions 
containing the purified enzymes were collected and dialyzed to remove the imidazole 
against 100 mM Tris-HCl, 200 mM NaCl, 0.1 mM EDTA, 0.1 mM DTT, 0.1% CHAPS 
(w/v) and 20% glycerol (v/v).  
 
2.3.3. Western Blot Analysis 
 
Solubilized CYP27B1, ADX and ADR prepared from recombinant E. coli cells were 
subjected to electrophoresis on 4-12% linear gradient polyacrylamide SDS gels and then 
transferred electrophoretically to nitrocellulose membrane using Semi-Dry Blotting unit 
(Fisher Biotech). CYP27B1, ADX and ADR membranes were probed with anti-
CYP27B1, anti-adrenodoxin and anti-adrenodoxin reductase antibodies (Abcam, USA) 
and then followed by FITC conjugated secondary antibody (Abcam, USA). Antibody 
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2.3.4. Measurement of CYP27B1 Activity and LC-MS/MS Analysis 
 
Activity measurements were carried out in a mixture consisting of 192 µM NADPH, 20 
µM human ADX, 0.45 µM ADR, 5-10 µM 25(OH)D3 and 100-200 µM CYP27B1, in a 
buffer containing 50 mM Tris-HCl, 0.1 mM EDTA, 0.1% CHAPS and 0.2% glycerol (pH 
7.4). After preincubation at 37 °C for 2 minutes, reactions were initiated with addition of 
NADPH. The reactions were stopped by addition of acetonitrile after 2-10 minutes (34). 
After quick centrifugation, the clarified supernatants were extracted with ethyl acetate 
and the organic phase was transferred and dried under nitrogen flow. The organic phase 
was then resuspended in 4-phenyl-1,2,4-triazoline-3,5 dione (PTAD, 1 mg/ml in 
acetonitrile) and left for derivatization for one hour at room temperature. The same 
volume of DI water was added to quench the reaction. Samples were injected into the 
LC-MS/MS for quantification of metabolites. Reverse-phase UPLC with a Waters BEH 
C18 column was used for separation of the products. The gradient was initiated with 50% 
solvent A (water with 0.1% formic acid) and 50% solvent B (acetonitrile with 0.1% 
formic acid), then solvent B was increased to 65% over 2.5 minutes, with a flow rate of 
0.3 mL/min. 
 
2.3.5. Chemical Synthesis of Cobalt Sepulchrate Trichloride 
 
The synthetic protocol was adapted from the literature (46). In brief, NH4OH (28% in DI 
H2O, 50 mL) and CH2O (37% w/w in H2O, 50 mL) were added separately to a stirring 
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suspension of Li2CO3 (2.303 g) and [Co(en)3]Cl3•3H2O (0.8989 g, 2.25 mmol) in DI H2O 
(20 mL) at a rate of 0.83mL/min utilizing peristaltic pumps. Upon complete addition of 
NH4OH and CH2O, the reaction mixture was stirred for an additional 45 minutes, after 
which any unreacted Li2CO3 was filtered off and rinsed with aliquots of DI H2O.  
 
A solution of Na[SCNEt2]•3H2O (0.222 M in DI H2O) was then added to the filtrate and 
the mixture was allowed to stir for 45 minutes. A dark orange-red solid was collected via 
vacuum filtration and was washed with 20:80 dichloromethane/hexane solution until the 
filtrate was no longer green in color. The crystals were dried under vacuum and then 
suspended in acetonitrile. Concentrated HCl was added drop-wise to the suspension, 
resulting in the formation of bright-yellow crystals and the solution turning yellow-green. 
The mixture was then heated for 10 minutes, and the crystals were collected via vacuum 
filtration and rinsed with aliquots of acetonitrile in 50.1% overall yield. 1H NMR (300 
MHz wide bore, D2O): δ(ppm) 4.0 (d, 12H), 3.3 (dd, 12H); UV/Vis (Molecular Devices 
SpectraMax M2 Spectrophotometer): λ 339.4nm (ϵ 115.4 M-1 cm-1), λ 469.7nm (ϵ 108.9 
M-1 cm-1). 
 
The 1H NMR spectrum of Co(sep)Cl3 dissolved in D2O is in agreement with values 
published in the literature (47). The UV-Vis spectrum exhibited a broad absorption band 
at 469.7 nm with ϵ = 108.9 M-1 cm-1 and a shoulder at 339.4 nm with ϵ = 115.4 M-1 cm-1; 
these values are in close agreement with λmax and ϵmax values published in the literature 
(48).  
	   30	  
2.3.6. Electrode Preparation and Electrochemical Measurements 
 
The working electrode was prepared by polishing the glassy carbon electrode (GCE) with 
aqueous slurry of 0.5µm alumina for one minute using a Buehler rotary polisher. The 
working electrode was then sequentially rinsed with methanol and DI H2O and sonicated 
in DI H2O for five minutes to remove residual polishing material. This process was then 
repeated a second time where the working electrode was sonicated in absolute ethanol for 
five minutes. The GCE was then rinsed with DI H2O and dried under a gentle nitrogen 
flow for approximately 5 minutes.  
 
Nafion-117 stock solution was diluted to 1% w/v using 2-propanol, and it was pH 
adjusted with Tris-buffer, yielding a 1% solution (pH 7.4) of solution A. This was 
followed by the preparation of a 1mM solution of Co(sep)3+ in 0.1 M PBS (pH 7.4), 
yielding solution B. Purified CYP27B1 was used as solution C. The following electrode 
coating procedure was used: 5µL of A was drop-cast onto the clean/dry GCE, followed 
sequentially by 5µL of B and 5µL of C. The electrode was then dried under a gentle flow 
of nitrogen for approximately 10 minutes. 
 
Upon receiving 25(OH)D3 from the manufacturer, it was dissolved in neat ethanol to 
make a 10 mM stock solution which was stored at -20°C. When needed for 
electrochemistry experiments, the stock solution was diluted with DI H2O to a 
concentration of 0.49µM; this solution was then serially diluted to obtain samples of 
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other substrate concentrations in the physiological range. Water-diluted samples were not 
stored for longer than the duration of the experiment.  
 
All electrochemical measurements were performed at room temperature (~25°C) using 
0.1 M PBS (pH 7.4) as electrolyte. In addition to the GCE working electrode, a Ag/AgCl 
(3M NaCl) reference electrode and a platinum wire counter electrode were used for all 
experiments. A salt-bridge-based electrochemical cell was created in order to enhance 
biosensor response. To construct the cell, a piece of Fisher-brand Q5 filter paper was 
saturated in electrolyte solution (1 mL) and placed into a petri dish. Electrodes were then 
placed in contact with the filter paper to allow for ionic current flow between them. A 
descriptive sketch of the cell can be found in Supporting Information (Fig S2.1 in 
Supporting Information). 
 
Cyclic voltammetric (CV) analyses were performed on an EG&G PAR 
Potentiostat/Galvanostat model 273A under the control of CorrWare software; CorrView 
software was used for the visualization of results. All CV experiments were conducted at 
a scan rate of 100 mV/s and across a variable range of potentials. Square wave 
voltammetric (SWV) analyses were carried out on a µAutolab potentiostat at 15 Hz, 4.05 
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2.4. Results 
 
The human CYP27B1 enzyme was expressed in E. coli with the assistance of chaperone 
protein GroEL/ES. The human CYP27B1 enzyme was partially purified using the 
appended polyhistidine-tag and immobilized metal affinity chromatography. Since 
CYP27B1 is a membrane-bound protein, CHAPS detergent was included for 
solubilization. No further purification was performed as the enzyme is known to be only 
marginally stable (28).   
 
SDS/PAGE (Fig 2.2(A)) and Western blot analysis (Fig 2.2(B)) were used to assess the 
enzyme expression and purification. Since it is partially purified, SDS/PAGE analysis 
does not show a clear band, but Western blot confirms expression of CYP27B1 with a 
major band at 60 kDa. ADR and ADX, which are two extrinsic electron transfer proteins 
necessary for the catalytic cycle, were also expressed in E. coli, and purified with 
immobilized metal affinity chromatography.  Purification of ADX and ADR were also 
assessed with SDS/PAGE and Western blot analysis (Fig 2.2), both confirming their 
purities. 
 
The hydroxylation of 25(OH)D to 1,25(OH)2D is catalyzed by CYP27B1 in the presence 
of NADPH as an electron donor, and ADX and ADR as electron-transfer proteins. In 
order to quantify the amount of 1,25(OH)2D and other possible metabolites that were 
produced, LC-MS/MS was used. After preincubation, the reactions were initiated with 
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the addition of NADPH. The reactions were stopped by addition of acetonitrile after 2-10 
minutes and analyzed with LC-MS/MS. Fig 2.3 (panels A and B) shows the liquid 
chromatography profile of a sample where all the reactants in the enzymatic assay are 
present. After comparing with retention time of the standards, we observed 1,25(OH)2D3 
production, which is eluted at 1.33 minutes (Fig 2.3(B)), whereas for the same sample we 
also observed the formation of a (OH)2D3 isomer, which has a retention time similar but 
not identical to 24,25(OH)2D3 (Fig 2.3(A)).  
 
Experiments were performed with varying concentrations of 25(OH)D3 present in the 
assay and compared to controls without the addition of CYP27B1. The top two panels of 
Fig 2.4 show the results for the production of 1,25(OH)2D3 (A) and the (OH)2D3 isomer 
(B) as a function of initial 25(OH)D3 present in the assay. Concentrations of both 
1,25(OH)2D3 and (OH)2D3 isomer increased linearly as the initial concentration of the 
reactant in the assay was increased. The control experiments indicated the presence of a 
background signal which is likely some 1,25(OH)2D3 and (OH)2D3 present in the 
25(OH)D3 stock solution.  
 
Kinetic experiments were also performed where the enzymatic reaction was stopped at 
different times in order to measure 1,25(OH)2D3 concentration as a function of time. Fig 
2.4(C) shows the amount of 1,25(OH)2D3 produced for different reaction durations. 
Product formation starts with a value of 3.5 nM, showing a rapid production of 
1,25(OH)2D3, reaching 6.5 nM after 6 minutes. Lastly, Fig 2.4(D) shows the final 
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concentration of 25(OH)D3 as a function of the initial concentration of the enzyme 
CYP27B1. We have observed that consumption of the substrate increased when the 
amount of CYP27B1 was increased in the assay, and this reaction is most relevant to the 
development of a sensor for Vitamin D detection. Experiments and controls summarized 
in Fig 2.4 suggest that recombinantly expressed CYP27B1 is successful in converting 
25(OH)D3 into the products 1,25(OH)2D3 and a (OH)2D3 isomer, although the yields for 
1,25(OH)2D3 are low.  
 
Electrochemical experiments performed in bulk electrolyte systems did not yield 
reproducible results, likely due to the dissolution of materials off of the working 
electrode. To overcome these problems, a salt-bridge cell, wherein the electrodes were 
placed flush against a piece of filter paper saturated in electrolyte, was constructed. 
Control experiments utilizing well-characterized redox mediators were performed to 
ensure that effective charge transfer between electrodes was possible before applying this 
system to the development of a vitamin D sensor. 
 
Cyclic voltammograms of the GCE/Nafion®/Co(sep)3+/CYP27B1 system demonstrated 
two cathodic peaks, one indicative of the Co3+/2+ transition at the more negative potential 
and the other occurring at the approximate redox potential of CYP27B1 (38). Square 
wave voltammetry experiments with the same system were in agreement with this 
observation (Fig S2.2 in Supporting Information). Both peaks were responsive upon the 
addition of substrate; however, in the absence of Co(sep)3+, the peak corresponding to the 
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Fe3+/2+ transition of the heme group was either not observed or poorly defined. Further 
control experiments with GCE/Nafion®/Co(sep)3+ system that were conducted using 
SWV confirmed this conclusion (Fig S2.3 in Supporting Information).  CVs of GCE 
modified only with Nafion® did not exhibit electrochemical activity as expected. Fig 2.5 
summarizes the various behaviors observed in CV analyses and suggests that the electron 




Testing for circulating vitamin D concentrations is presently achieved using costly and 
prolonged techniques. In order to develop a rapid way of measuring it, an enzyme 
modified electrode sensitive to 25(OH)D3 has been improved. As a first step, the human 
CYP27B1 enzyme was made, and its activity was determined using LC-MS/MS. The 
purified CYP27B1 was immobilized on a glassy carbon electrode with the redox 
mediator Co(sep)3+ and Nafion® membrane. The performance of this modified electrode 
was characterized electrochemically, using cyclic and square wave voltammetry. 
 
The CYP27B1 enzyme is able to catalyze the conversion of 25(OH)D3 to 1,25(OH)2D3. 
A codon-optimized version of the human CYP27B1 gene was expressed in E. coli and 
partially purified. LC-MS/MS results show that under in vitro conditions, in addition to 
the expected 1,25(OH)2D3 production, the enzyme also catalyzes the formation of a 
(OH)2D3 isomer, similar to 24,25(OH)2D3. Possibly, when CYP27B1 is expressed in a 
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bacterial expression system, some of the specificity of the reaction is lost. Uchida et al. 
(34) showed that fractions of overexpressed CYP27B1 are capable of 1α hydroxylation of 
both vitamin D3 and 25(OH)D3, the former not observed in vivo. Furthermore, Sawada et 
al., (35) and Sakaki et al. (36) demonstrated that human and mouse CYP27B1, 
respectively, overexpressed in a bacterial system metabolize 1α hydroxylation of 
24,25(OH)2D3 as well as 25(OH)D3. However, there is no specific report showing 
CYP27B1 catalyzing the formation of a (OH)2D3 isomer similar to 24,25(OH)2D3. Thus, 
an increased catalytic flexibility of this membrane-associated enzyme in an in vitro 
setting might explain the production of this isomer. 
 
An important milestone for amperometric detection of 25(OH)D3 is the immobilization of 
active CYP27B1 onto an electrode. A recent study reported the use of the CYP27B1 
enzyme from mouse kidney and its immobilization onto an edge plane pyrolytic graphite 
electrode with a surfactant (39). Although the heme group could electrochemically be 
detected, the surfactant used to solubilize and immobilize the enzyme was thought to 
have a deleterious impact on catalytic activity, and the system failed to quantify 
25(OH)D3 concentration electrochemically. Key differences in the present approach 
include use of Co(sep)3+ as a redox mediator and of a Nafion® film for immobilization.  
 
In cases where the redox center of an enzyme is buried in the structure and/or it is hard to 
detect the direct electron transfer to enzyme, an electrochemically active species (called a 
mediator) is used. This mediator first changes its redox state at the electrode and then 
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shuttles the electrons to the redox site of the enzyme (49). It is therefore possible to 
follow the response of the enzyme to its substrate by observing the changes in 
oxidation/reduction peak current of the mediator. Previous studies with various CYP450s 
showed that Co(sep)3+ behaved as a mediator, in other words, detection of the 
corresponding substrates was possible by following the changes in the 
oxidation/reduction peak current of Co(sep)3+ (40-42). However, the presently 
constructed electrodes show electrochemical responses at the redox potential of Co(sep)3+ 
as well as that of the heme group (Fig 2.5, Fig S2.2-S2.3 in Supporting Information). In 
addition, a clear heme group peak was poorly defined in the absence of Co(sep)3+ in film, 
suggesting that Co(sep)3+ may enhance the electron transfer from the electrode to the 
heme group of CYP27B1. Amplification of the heme group signal with the addition of 
25(OH)D3 in the presence of Co(sep)3+ suggests further that the mode of detection might 
be similar to direct electron transfer mechanisms. This mechanism is also analogous to 
the ones that were suggested by Abouzar et al. (19) and Poghossian et al. (20), where 
they use gold nanoparticles and polyelectrolyte multilayer to modify the sensor, 
respectively, and detect the changes in charged molecules directly. 
 
The electrochemical detection of heme group in the presence of Co(sep)3+ on the film 
suggests that Co(sep)3+ may function as more than a mediator (i.e. as a ‘promoter’). 
Despite the fact that it is not directly associated with the development of a new method 
for detection of 25(OH)D3, it is important to understand the electron transfer process in 
this system and why Co(sep)3+ might be acting differently than a typical redox mediator. 
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It is possible that electrostatic interactions of the enzyme are altered due to the presence 
of Co(sep)3+. The crystal structure of CYP27B1 is not available; however, previous 
simulation studies with another CYP450 crystal structure showed that substrate access 
channel of this enzyme has enough room to accommodate a molecule such as Co(sep)3+ 
(50-52). Therefore, electrostatic interactions of positively charged Co(sep)3+ at the 
entrance of this channel might have effects on electron transfer rates to the redox center 
and on substrate binding (52). Moreover, interaction of Co(sep)3+ with the enzyme might 
alter the orientation of the latter so that heme group can be more accessible for electron 
transfer (53). Another explanation for this ‘more-than-a-mediator’ behavior of Co(sep)3+ 
might be due to cation-induced interfacial interactions (54-55). Armstrong et al. (54) 
demonstrated that use of multivalent cations such as Mg2+ and Co(NH3)63+ increased the 
electron exchange rate of a copper-containing protein and suggested that these cations 
may enhance the electron transfer.  
 
The proof-of-concept developed in this study demonstrates that the detection of 
25(OH)D3 in buffer is possible, although behavior of the modified electrode across 
various 25(OH)D3 concentrations has yet to be determined. The sensor is sensitive to 
25(OH)D3 in the physiological range (5-200 ng/ml) although optimization of the 
electrode assembly and mode of detection will be required in order to operate the sensor 
in the entire range. Furthermore, specificity of the modified electrode and 25(OH)D 
detection from blood-derived aliquots will be an important next step to determine the 
impact of interferents. 




The human CYP27B1 enzyme has been expressed in E. coli, partially purified and its 
activity has been demonstrated using LC-MS/MS. A glassy carbon electrode modified 
with this enzyme, a non-native redox mediator Co(sep)3+, and pH-adjusted Nafion® has 
been shown to respond to the circulating form of vitamin D, 25(OH)D3. Using cyclic and 
square wave voltammetry, the GCE/Nafion®/Co(sep)3+/CYP27B1 electrode has been 
shown to be successful in detecting 25(OH)D3 in buffer within the physiological range 
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Figure 2.1. Electron transfer mechanisms in CYP450s. (A) Native mechanism with 





	   41	  
 
 
Figure 2.2. Analysis of purity of CYP27B1, ADX and ADR. (A) SDS/PAGE of 
CYP27B1 (lane 2), ADX (lane 3), and ADR (lane 4) after nickel affinity 
chromatography. (B) Western blot of CYP27B1 (lane 2), ADX (lane 3), and ADR (lane 
4) after nickel affinity chromatography. Lane 1 (leftmost one in both panels) is the 
protein standard.  
 





Figure 2.3. Characterization of products with liquid chromatography. All the reactants in 
the enzymatic assay are present. Filled area in the panel A shows (OH)2D3 isomer and 
filled area in the panel B shows 1,25(OH)2D3 for the same sample. Abscissa shows the 











Figure 2.4. Results of the kinetic experiments. LC-MS/MS was used to quantify the 
concentration of products and other metabolites. The experiments were conducted at least 
in duplicate and error bars represent the standard error. (A) Concentration of 
1,25(OH)2D3 produced as a function of initial 25(OH)D3 concentration with the complete 
reaction mixture (♦) and without the addition of CYP27B1 (■). (B) Concentration of 
(OH)2D3 isomer produced as a function of initial 25(OH)D3 concentration with the 
complete reaction mixture (♦) and without the addition of CYP27B1 (■). (C) 
Concentration of 1,25(OH)2D3 produced over time with the complete reaction mixture (♦) 
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and without the addition of CYP27B1 (■). (D) Final concentration of 25(OH)D3 left in 
the reaction as a function of concentration of CYP27B1 in the assay. 
 
 
Figure 2.5. Representative cyclic voltammograms. Modified working electrode behavior 
of (*) GCE/Nafion®/Co(sep)3+, (●) GCE/Nafion®/Co(sep)3+/CYP27B1, and (□) 
GCE/Nafion®/Co(sep)3+/CYP27B1 following the addition of 10µL of 205.1 ng/mL 
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2.8. Supporting Information 
 
 
Figure S2.1. A descriptive sketch of the electrochemical cell. 
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Figure S2.2. Representative square wave voltammograms. Modified working electrode 
behavior of (¢) GCE/Nafion®/Co(sep)3+, and (□)GCE/Nafion®/Co(sep)3+/CYP27B1. 
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Figure S2.3. Square wave voltammograms of Co(sep)3+ modified electrode. (¢) No 
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Table S2.1. Primer sequences for cloning of human CYP27B1, ADX and ADR. 
Primer Sequence 
pr1 5’ CGAGTATCATATGGCGCGTCGCTCC 3’ 







pr5 5’ AAGGACCATAGCATAATGAGCACTCAAGAACAAACTCC 3’ 
 
Table S2.2. Sequence of the human CYP27B1 gene that was codon optimized for E. coli 











































Table S2.3. Amino acid sequences of CYP27B1, ADR and ADX. 
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CHAPTER 3 
Kinetic and Transport Effects on Biocatalysis 
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A version of this chapter, titled as “Kinetic and Transport Effects on Enzymatic 
Biocatalysis Resulting from PEGylation of Cofactors”, is in press for publication on 




The utilization of cofactor-dependent redox enzymes in bioprocess technologies requires 
low cost cofactor regeneration methods. PEGylated NAD(H) (PEG-NAD(H)) has been 
utilized in enzyme membrane reactors as a means to recover the cofactor; however, there 
is a lack of understanding of the effect of PEGylation on enzymatic activity, especially on 
the relationship between biocatalysis and transport phenomena. To explore this further, 
two redox enzymes (formate dehydrogenase (FDH) from S. cerevisiae and NAD(H)-
dependent D-lactate dehydrogenase (nLDH) from E.coli) have been chosen and the 
kinetic effects caused by cofactor modifications (with PEG of three different chain 
lengths) have been investigated. The PEGylation did not impact the cofactor dissociation 
constants and mass transfer was not the rate-limiting step in biocatalysis for either 
enzyme.  However, the PEG chain length had different impacts on the formation of 
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3.2. Introduction 
 
As in vitro synthetic pathways are developed for different applications, enzymes such as 
dehydrogenases and reductases that are able to perform redox reactions are increasingly 
being utilized. The enzymes often require soluble cofactors for electron transport, which 
can be critical bottlenecks in these applications due to their high cost, low stability, and 
limited abundance in living cells (1-2). Therefore several cofactor regeneration systems 
have been explored and developed to address some of these limitations. Some approaches 
that have been developed for cofactor regeneration include chemical, electrochemical and 
enzymatic methods (3-4).  
 
A significant challenge in working with cofactor-dependent enzymes is the fact that the 
oxidized and reduced cofactors are generally mixed with the reactants and products 
during catalysis steps.  The separation of cofactors from the desired products is an 
important issue, and in some cases, the cofactors are more valuable than the other 
products of the reaction, making cofactor recovery and recycling essential (3).  One 
approach is to use membranes to separate cofactors, and the effectiveness of this can be 
enhanced if the molecular weight of the cofactors is increased by chemical modification 
(5). In these systems, cofactors are tethered to larger molecules such as dextran or 
polyethylene glycol (PEG) via chemical methods, and membranes with pore sizes that are 
larger than the products but smaller than the modified cofactors are utilized for cofactor 
recovery (4). 
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PEGylated NAD(H) (PEG-NAD(H)) is one such cofactor that has been used in enzyme 
membrane reactors, with research focused mainly on improving reactor performance 
(such as obtaining higher total turnover numbers) (4). Most of these studies have utilized 
only a few versions of PEG-NAD(H) and the impact of these modifications on enzymatic 
activity have not been thoroughly investigated (6-9). Thus there is a need to better 
understand the interplay between transport (of size-modified cofactors) and biocatalysis 
(with these cofactors).  This can guide further efforts aimed at modifying the enzymes to 
better accommodate modified cofactors and to improve process designs. 
 
Here, we have selected two different redox enzymes and explored PEG-NAD(H) with 
three different chain lengths and we report thorough kinetic impacts of these cofactor 
modifications (Figure 3.1). The enzymes of interest are S. cerevisiae formate 
dehydrogenase (FDH), which oxidizes formate to CO2 while reducing NAD+ to NADH 
(10-11), and E. coli NAD(H)-dependent D-lactate dehydrogenase (nLDH), which reduces 
pyruvate to D-lactate while oxidizing NADH to NAD+ (12). FDH was selected because it 
has been used for cofactor regeneration (11), its substrate formate is inexpensive, and its 
product CO2 does not accumulate in the system. nLDH, on the other hand, is a model 
enzyme for reductive dehydrogenases with its substrate pyruvate being a central node in 
biological pathways. Thus, these studies can help us (a) better understand the impact of 
PEGylation of cofactors on the relationship between mass transfer and catalysis in 
engineered biocatalytic cascades and bioprocesses and (b) gain insights into whether 
protein engineering can be utilized to address performance issues in these systems. 
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Carboxylic acid functionalized methoxyl polyethylene glycol (PEG-COOH) of molecular 
weights 3 kDa, 5 kDa and 10 kDa were purchased from Nanocs Inc. (Boston, MA, USA). 
N-hydroxysulfosuccinimide (Sulfo-NHS) was purchased from Thermo Fisher Scientific 
(New York, NY, USA). All other chemicals were purchased from Sigma Aldrich (St. 
Louis, MO, USA) unless specified otherwise. 
 
3.3.2. Cloning, Expression, and Purification of Enzymes 
 
DNA encoding S. cerevisiae formate dehydrogenase (FDH) was amplified via PCR using 
forward primer 5’-CATATGTCGAAGGGAAAGGTTTTGC-3’ and reverse primer 5’-
TTTCTTCTGTCCATAAGCTCTGGT-3’ and cloned into the pTrcHis2-TOPO vector 
(Thermo Fisher Scientific). Colonies harboring the desired plasmid were transformed into 
E.coli BL21-A1 expression cells. For expression, 10 ml of overnight culture was added 
into 1 L Terrific Broth (TB) media that includes 50 µg/ml ampicillin and cells were 
grown until OD600 reached ~0.6. Following induction with 1 mM isopropyl-β-D-1-
thiogalactopyranoside (IPTG) and 0.2% L-arabinose, cells were grown at 25 °C for 14-18 
h. Cells were centrifuged at 4 °C at 6000 rpm for 8 minutes. For purification, cell pellets 
were suspended in a buffer with 20 mM Tris-HCl (pH 7.4), 200 mM NaCl, and 20 mM 
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imidazole. After sonication, the solution was cleared by centrifugation and the 
supernatant was applied to HisTrap columns (GE Healthcare, Piscataway, NJ, USA). 
Elution was performed with 75-500 mM imidazole in 20 mM Tris-HCl (pH 7.4), and 200 
mM NaCl. Fractions were run on SDS-PAGE and those with desired band (45.4 kDa) 
were pooled and buffer exchanged into 20 mM Tris-HCl, pH 7.4. 
 
DNA encoding E. coli NAD(H)-dependent D-lactate dehydrogenase (nLDH) was PCR 
amplified with forward primer 5’-CATATGAAACTCGCCGTTTATAGCACA-3’ and 
reverse primer 5’-AAGCTTAACCAGTTCGTTCGGGC-3’ and ligated into pET20b 
vector using restriction enzymes NdeI and HindIII. Colonies harboring the desired 
plasmid were transformed into E. coli BL21(DE3) expression cells. For expression, 10 ml 
overnight culture were added into 1 L TB media that included 100 µg/ml ampicillin, and 
cells were grown until OD600 reached ~0.6. Following induction with 0.5 mM IPTG, 
cultures were incubated at 37 °C for 14-18 h. Cells were centrifuged at 4 °C at 6,000 rpm 
for 8 minutes. For purification, cell pellets were resuspended in 50 mM HEPES (pH 8.0), 
150 mM NaCl, and 10 mM imidazole. After sonication, solutions were clarified by 
centrifugation and supernatants were applied to HisTrap columns (GE Healthcare, 
Piscataway, NJ, USA). Elution was performed using 10-250 mM imidazole in 50 mM 
HEPES (pH 8.0) and 150 mM NaCl. Fractions were run on SDS-PAGE and those with 
desired band (38 kDa) were pooled and buffer exchanged into 20 mM Tris-HCl, pH 7.4. 
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3.3.3. Attachment of PEG-COOH to NAD(H) 
 
PEG-COOH was coupled to the primary amine group in the adenine moiety of NAD+ or 
NADH using N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) 
and sulfo-NHS by following the protocol of the manufacturer (Thermo Fisher Scientific). 
After the coupling reaction, PEG-NAD(H) was buffer exchanged (at least 3 times) into 
20 mM Tris-HCl (pH 7.4) with centrifugal filter units and immediately used for activity 
assays. 
 
3.3.4. Kinetic Experiments 
 
All kinetic reactions were conducted in 20 mM Tris-HCl (pH7.4) buffer at 25 °C by 
following absorbance of NADH or PEG-NADH at 340 nm. For FDH, the initial 
concentration of sodium formate varied between 10-250 mM, and the cofactors varied 
between 0.1-1.5 mM. For nLDH, the initial concentration of sodium pyruvate varied 
between 5-30 mM, and the cofactors varied between 25-125 µM. Reactions were initiated 
with the addition of enzyme and run for 20 minutes. Experiments were performed in 
triplicate. The extinction coefficient of NADH (6.22 mM-1 cm-1) at 340 nm was not 
affected by PEGylation and this value was used to convert the absorbance data into 
cofactor concentrations. Initial rates were measured for each cofactor and substrate 
concentration, and these rates were fitted to the ordered bi-bi kinetic equation (Eqn 1)	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(13) using IgorPro (Wavemetrics Inc., Portland, OR, USA) to estimate kinetic 
parameters. 
𝑣 =    𝑘!"# ∗ 𝐶 ∗ [𝑆]𝐾!,!"# ∗ 𝐾!,! + 𝐾!,!"# ∗ 𝑆 + 𝐾!,! ∗ 𝐶 + 𝐶 ∗ [𝑆]                         (𝐸𝑞𝑛  1) 
v is the initial rate, [C] is the cofactor concentration and [S] is the substrate concentration. 
kcat is the catalytic turnover rate, Km,cof and Km,S are Michaelis constant for cofactor and 
substrate, respectively, and Ki,cof is the cofactor dissociation constant. One-way ANOVA 
(with p < 0.05) was performed for all kinetic parameters to determine statistical 
significance using Prism (version 7, GraphPad Software Inc., La Jolla, CA).  
 
3.4. Results and Discussion 
 
Genes encoding FDH and nLDH were PCR amplified, expressed in E. coli, and purified 
by immobilized metal affinity chromatography. SDS-PAGE analysis of the purified 
enzymes is shown in Figure S3.1.  Activity assays were performed for both enzymes with 
their respective substrates and cofactors, and they were repeated with different PEG-
NAD(H) constructs under identical experimental conditions. Initial rate data were fit to 
the ordered bi-bi kinetic equation (Eqn 1) to determine steady-state kinetic parameters 
and the values are tabulated in Table 3.1. It was observed that whereas kcat did not 
significantly change with cofactor molecular weight for FDH, the same value decreased 
significantly from 3,600 to 32 s-1 with increasing cofactor molecular weight for nLDH.  
The opposite trend was observed with the Km values, where the increase in the cofactor 
molecular weights significantly increased the Km value for cofactor for FDH but less of 
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an effect was seen with substrate and for both Km values for nLDH.  And most 
surprisingly, there was no clear effect of the cofactor size on the dissociation constants 
for cofactor for either enzyme. This demonstrates that the alterations of the cofactor do 
not change the overall affinities of the enzymes for the cofactors.   
 
The first steps of the ordered bi-bi mechanism can be written as follows, where E stands 
for enzyme, C for cofactor and S for substrate	  (14): 𝐸 + 𝐶 !! 𝐸 ⋅ 𝐶                                                                                                                        (𝑆𝑡𝑒𝑝  1) 
𝐸 ⋅ 𝐶 !! 𝐸 + 𝐶                                                                                                                      (𝑆𝑡𝑒𝑝  2) 𝐸 ⋅ 𝐶 + 𝑆 !! 𝐸 ⋅ 𝐶 ⋅ 𝑆                                                                                                              (𝑆𝑡𝑒𝑝  3) 
Here, k1 is forward rate of Step 1, or on-rate of cofactor, and can be calculated from 
kcat/Km,cof; k2 is the reverse rate of Step 1, or off-rate of cofactor, and can be calculated 
from kcatKi,cof/Km,cof; and k3 is net on-rate of substrate and can be calculated from kcat/Km,S. 
These individual rate constants are tabulated in Table 3.2. For both enzymes, there is a 
decrease the k1, k2, and k3 values upon PEGylation of the cofactors for all chain lengths.   
However no further correlation was observed for the effect of PEG chain lengths on the 
rate constants. 
 
In order to determine if the individual rate constants were decreasing due to mass transfer 
limitations resulting from the increased molecular weights of the cofactors, the mass 
transfer parameters were estimated (Supplementary Information) and compared to the 
kinetic rate constants as a function of cofactor molecular weight (Figure 3.2). Increasing 
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the cofactor molecular weight leads to a dramatic decrease in transport rate constants; 
however, even the smallest transport rate constant value (not smaller than ~107 s-1) is 
significantly larger than any of the catalytic turnover rates (up to ~103 s-1) or any of 
cofactor on or off-rates (up to ~105 s-1 mM-1). Thus, it can be concluded that transport of 
the cofactor is not a rate-limiting step and changes in the kinetic values are unlikely to be 
limited by cofactor diffusion. 
 
Further comparison between transport and chemical reaction steps can be made by 
calculating a “cofactor (or substrate) modulus” using the following formula, where µ is 
cofactor modulus, [Et] is total enzyme concentration, and ktr is transport rate constant	  
(15): 
𝜇 = 𝑘!"# ∗ [𝐸!]𝑘!" ∗ 𝐾!,!"#                                                                                             (𝐸𝑞𝑛  2) 
In this formula, the denominator represents the effect of transport whereas the numerator 
represents the rate of the chemical reaction. Although originally developed to estimate 
diffusional effects for heterogeneous biological systems (such as immobilized enzymes), 
this modulus can be estimated in this case using the experimentally determined kinetic 
parameters and the impact of cofactor molecular weight on this parameter can be 
evaluated (Figure 3.3). As long as the value of this modulus is less than 10-1, kinetic 
effects are dominant, while values greater than 10 indicated diffusional limitations	  (15).  
The values in this work range from 10-6-10-5 verifying that cofactor diffusion is not the 
rate-limiting step in these systems.  Although diffusion is not rate limiting, Figure 3.3(A) 
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shows a correlation between cofactor modulus and molecular weight for FDH and PEG-
NAD+, but this is less evident for nLDH and PEG-NADH (Figure 3.3(B)).   
 
Using the steady-state on- and off-rates in Table 3.2, a catalytic efficiency (k1k3/k2) can be 
calculated	   (16)	  and compared as a function of cofactor molecular weight. For FDH, the 
catalytic efficiency of the enzyme with PEGylated cofactors is 40-50% of that of enzyme 
with unmodified NAD+. In the case of nLDH, PEGylating NADH affects catalytic 
performance of the enzyme more drastically, as the values with modified cofactors are 
only 2-4% of efficiency with unmodified NADH.  
 
A closer examination of the mechanistic steps of the enzymatic reactions can provide 
some insights into the differential effects of cofactor PEGylation on biocatalysis.  
Although the effects of PEG chain length on cofactor dissociation constants (Ki,cof, Table 
3.1) were small, the impact of PEG length on the on-rates (k1) and off-rates (k2) were 
much larger (Table 3.2).  However, the changes were always similar in magnitude for 
both k1 and k2 so that the overall affinity of the enzyme for the PEGylated cofactors was 
less affected.  This could be explained by a boundary layer effect, where PEGylated 
cofactor is released and rebound without returning to the bulk, leading to an unchanged 
dissociation constant.  This observation is also consistent with the notion that the system 
is not transport limited, as one might expect on-rates of material coming from the bulk to 
change with alterations in diffusivity of the cofactor while the off-rates could be less 
affected under these dilute conditions.  Thus equal changes in on- an off-rates seen here 
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are consistent with addition of the PEG chain slowing both the formation of the 
cofactor/enzyme complex and then equally slowing the release of these complexes, 
leading to only minor changes in overall affinity. 
 
Changes in k1 values can also be compared to changes in kcat/[Et] values (kcat was divided 
by [Et] to normalize units) (Table 3.3). For FDH, decreases in catalytic turnover rate are 
not as notable as that of the on-rate of cofactor. In other words, while k1 and k2 were 
reduced as the molecular weight of cofactor increased, kcat was largely unaffected. Thus, 
it is likely that only docking of cofactor to the enzyme active site (Step 1 of the reaction 
scheme shown before) is impacted by the tethering of PEG to the cofactor. The opposite 
was observed for nLDH, where trends for turnover and cofactor on-rates are similar to 
each other. Thus, modifying the cofactor with larger PEGs not only affected the docking 
of the cofactor to the enzyme, but also interferes with the formation of the 
enzyme/cofactor/substrate ternary complex, which reduces the catalytic turnover rate of 
the enzyme. 
 
Kinetic parameters can also be used to quantify thermodynamic impacts on enzyme 
performance.  The changes in cofactor ground- and transition-state binding energies 
compared to the native cofactors were calculated using equations 3 and 4	   (17), and 
compared (Table 3.4): ∆∆𝐺! = −𝑅𝑇 ln[(𝐾!,!"#)!"#(!)/(𝐾!,!"#)!"#!!"#(!)]                                           (𝐸𝑞𝑛  3) ∆∆𝐺! = 𝑅𝑇 ln (𝑘!"# 𝐾!,!"#)!"# ! (𝑘!"# 𝐾!,!"#)!"#!!"# !                           𝐸𝑞𝑛  4  
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Here, ΔΔGg and ΔΔGt are the changes in ground and transition state binding energies, 
respectively, R is universal gas constant, and T is absolute temperature. Overall the 
changes in the ground state energy of cofactor binding between the extended and native 
cofactors were small with values varying in the range of -0.66 to 0.47 kcal/mol and there 
was no obvious trend with changes in the size of the PEG chain.  In contrast, changes in 
the transition state binding energies between the modified and native cofactor were more 
substantially affected, and the impact was a function of the cofactor molecular weight for 
both enzymes. As the cofactor is made larger, losses in the binding energy increased up 
to 2.0 kcal/mol for FDH, whereas the energy loss was even higher for nLDH, changing 
from 2.4 to 2.8 kcal/mol.  
 
It is possible to explore the catalytic mechanisms of these enzymes using available 
structural information.  The crystal structure of E. coli nLDH has been recently deposited 
(PDB ID: 3WX0), and the nLDH from Lactobacillus bulgaricus (PDB ID: 1J49) can also 
be used as a model structure as these enzymes share a 30% sequence identity	  (18).  For 
FDH, the Pseudomonas sp. 101 FDH (PDB ID: 2NAD) can be used as a model the S. 
cerevisiae FDH as they share a 49% sequence homology	  (19).  Both enzymes belong to 
the “D-specific 2-hydroxyacid dehydrogenase” family and contain the classic Rossmann 
fold structure for cofactor binding	  (18-21). 
 
	   73	  
The amino acids that interact with the cofactors in the bound conformation are well 
understood. In this study, the cofactor was PEGylated at the primary amine of the adenine 
moiety. There is a glutamic acid at position 260 in Pseudomonas sp. 101 FDH that forms 
a hydrogen bond with amine group upon cofactor binding	  (19).  In the S. cerevisiae FDH, 
an aspartic acid is found at this position and likely forms the same hydrogen bond with 
the –NH2 group of NAD+.  For nLDH, there is an asparagine at residue 212 of L. 
bulgaricus nLDH that forms hydrogen bonds with adenine moiety of NADH including 
the primary amine group	  (18) and this residue is also conserved at E. coli nLDH. Since 
the dissociation constants for cofactor both enzymes were largely unaffected by the 
PEGylation of the cofactor, we can assume that these bonds are likely not disrupted.   
  
The catalytic mechanisms of both of these enzymes involve a dramatic conformational 
change where the structures transition from an open to closed conformation, enabling the 
hydride transfer step between the bound cofactor and substrate.  Based on the results 
from this study, it seems likely that the PEGylation of the cofactors may impact these 
conformational changes in both enzymes, but with different effects.  In the FDH enzyme, 
presence of the PEG group affects the binding energy and thus the efficiency of the 
formation of the ternary complex but at high reactant concentrations the overall 
maximum rate values are unchanged.  In the nLDH enzyme, the PEG group has a greater 
impact on the binding energy and also the conformational change, and thus the overall 
turnover rate of the enzyme is drastically reduced.  Pre-steady state kinetic analysis could 
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be performed in future work to quantify the impact of the PEG groups on the specific 




The PEGylation of cofactors can be used to facilitate their separation from reaction 
products in enzymatic bioprocesses.  Here we find that PEGylation can reduce enzymatic 
activity but not because of impacts on mass transfer of the cofactors to the enzymes.  
Instead, the PEGylation affects the rate of formation of enzyme/cofactor complexes 
and/or the formation of enzyme/cofactor/substrate complexes.  Thus the dominant effect 
of cofactor PEGylation is related to altered interactions between the enzyme and 
modified cofactors, and these interactions could potentially be addressed through protein 
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3.6. Figures and Tables 
 
 
Figure 3.1. Schematic of experiments in this study. Carboxylic acid modified PEG was 
chemically tethered to NAD(H) using EDC-NHS chemistry. Kinetic experiments were 
conducted for three different PEG-chain lengths attached to NAD(H). Formate 
dehydrogenase (FDH) oxidizes formate to carbon dioxide while reducing PEG-NAD+ 
and NAD(H)-dependent D-lactate dehydrogenase (nLDH) reduces pyruvate to D-lactate 
while oxidizing PEG-NADH. 
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Figure 3.2. Transport rate constants for (A) PEG-NAD+ and (B) PEG-NADH as a 
function of molecular weight.  
 
 
Figure 3.3. Cofactor modulus for (A) PEG-NAD+ and (B) PEG-NADH as a function of 
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Table 3.1. Steady-state kinetic parameters for FDH (with NAD+ and derivatives as a 
cofactor) and nLDH (with NADH and derivatives as a cofactor) 
 
NAD+-nK or NADH-nK is a cofactor that was modified with PEG, where n is the 
molecular weight of PEG. NAD+ and its derivatives were used with FDH for oxidation of 
formate to CO2 whereas NADH and its derivatives were used with nLDH for reduction of 
pyruvate to D-lactate. Reactions were performed in triplicate, with reported errors as 
standard error of mean. Asterisk denotes statistically significant difference from non-









Cofactor kcat (s-1) Km,cof (mM) Km,S (mM) Ki,cof (mM) 
NAD+ 2.0 ± 0.1 0.040 ± 0.020 17 ± 4 0.67 ± 0.28 
NAD+-3K 2.7 ± 0.4 0.75 ± 0.20 110 ± 40 0.27 ± 0.16 
NAD+-5K 2.7 ± 0.2 0.72 ± 0.16 30 ± 13 1.5 ± 0.9 
NAD+-10K 2.5 ± 0.4 1.2* ± 0.4 130 ± 50 0.22 ± 0.21 
NADH 3600 ± 600 0.029 ± 0.020 6.6 ± 4.7 0.39 ± 0.27 
NADH-3K 89* ± 14 0.045 ± 0.007 7.7 ± 5.3 0.23 ± 0.16 
NADH-5K 44* ± 6 0.027 ± 0.016 1.3 ± 2.5 0.59 ± 1.3 
NADH-10K 32* ± 7 0.028 ± 0.027 3.8 ± 5.2 0.26 ± 0.40 
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Table 3.2. Individual rate constants for FDH activity with NAD+ and nLDH activity with 
NADH 
 
Cofactor k1 (s-1 mM-1) k2 (s-1) k3 (s-1 mM-1) 
(k1k3/k2)  
(s-1 mM-2) 
NAD+ 55 ± 30 37 ± 25 0.11 ± 0.03 0.17 ± 0.08 
NAD+-3K 3.6 ± 1.1 0.95 ± 0.64 0.024 ± 0.008 0.089 ± 0.060 
NAD+-5K 3.8 ± 0.9 5.6 ± 3.9 0.091 ± 0.042 0.061 ± 0.050 
NAD+-10K 2.0 ± 0.7 0.44 ± 0.45 0.019 ± 0.007 0.088 ± 0.090 
NADH 130000 ± 90000 48000 ± 47000 550 ± 410 1400 ± 1400 
NADH-3K 1900 ± 400 460 ± 340 11 ± 8 49 ± 49 
NADH-5K 1600 ± 1000 970 ± 2100 34 ± 69 58 ± 170 
NADH-10K 1100 ± 1100 290 ± 530 8.5 ± 12 33 ± 68 
 
NAD+-nK or NADH-nK is a cofactor that was modified with PEG, where n is the 
molecular weight of PEG. On- and off-rate constants were calculated from steady-state 
kinetic parameters in Table 1. k1 is on-rate of a cofactor can be calculated from kcat/Km,cof, 
k2 is off-rate of a cofactor and can be calculated from kcatKi,cof/Km,cof and k3 is net on-rate 
of the substrate and can be calculated from kcat/Km,S. The combined parameter (k1k3/k2) 
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Table 3.3. Ratio of steady-state catalytic turnover rate constants, cofactor on-rate 
constants, and catalytic efficiencies for NAD(H)-nK versus NAD+ for FDH and NADH 
for nLDH 
 
Cofactor (kcat/[Et])/(kcat/[Et])NAD(H) (k1)/(k1)NAD(H) 
NAD+ 1.00 1.00 
NAD+-3K 0.67 0.06 
NAD+-5K 0.68 0.07 
NAD+-10K 0.63 0.04 
NADH 1.00 1.00 
NADH-3K 0.02 0.02 
NADH-5K 0.01 0.01 
NADH-10K 0.01 0.01 
 
NAD+-nK or NADH-nK is a cofactor that was modified with PEG, where n is the 
molecular weight of PEG. [Et] is the total enzyme concentration that was used in the 
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Table 3.4. Change in ground state and transition state binding energies compared to those 
obtained with unmodified NAD+ or NADH 
 
Cofactor ΔΔGg (kcal/mol) ΔΔGt (kcal/mol) 
NAD+-3K/NAD+ -0.55 1.6 
NAD+-5K/ NAD+ 0.47 1.6 
NAD+-10K/ NAD+ -0.66 2.0 
NADH-3K/NADH -0.30 2.4 
NADH-5K/NADH 0.25 2.6 
NADH-10K/NADH -0.24 2.8 
 
NAD+-nK or NADH-nK is a cofactor that was modified with polyethylene glycol, where 
n is the molecular weight of PEG. ΔΔGg is change in ground state binding energies, 
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3.7. Supplementary Information 
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Table S3.1. Amino acid sequences of enzymes used in this study 
 
Name Amino Acid Sequence 






























3.7.1. Estimation of Transport Rate Constants 
 
Transport rate constants (ktr) of PEG-NAD(H) have been calculated using the following 
formula	  (22):  𝑘!" = 𝑘! ∗ 𝑎!                                                                                                              (𝐸𝑞𝑛  𝑆1)  
where kL is the mass transfer coefficient and am is surface-to-volume ratio for cofactor. 
For a stagnant medium, kL can be estimated from film theory	  (23): 
𝑘! = 𝐷!"#𝑅!,!"#                                                                                                                 (𝐸𝑞𝑛  𝑆2) 
And surface-to-volume ratio of PEG-NAD(H) can be approximated as: 
𝑎! = 3𝑅!,!"#                                                                                                               (𝐸𝑞𝑛  𝑆3) 
In Equations S2 and S3, DPEG and Rh,PEG is diffusion coefficient and viscosity radius of 
PEG-NAD(H). These values were approximated using previously published values of 
PEG in water. According to Flory’s scaling law, for polymers, diffusion coefficient at 
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infinite dilution (D0) and viscosity radius (Rh) can be found as a function of molecular 
weight (Mw) as	  (24):  𝐷! = 𝐾! ∗𝑀!!∝                                                                                                  (𝐸𝑞𝑛  𝑆4) 𝑅! = 𝐾! ∗𝑀!∝                                                                                                       (𝐸𝑞𝑛  𝑆5) 
Here, KD and KR are scaling prefactors and α is scaling index. Based on a recent study, 
diffusion coefficient slightly changes with concentration at low molecular weight PEGs, 
so for our purposes, we assumed DPEG = D0,PEG	   (24). For diffusion coefficient, KD = 
1.12*10-8 m2/s, and α = 0.597	  (25), whereas for viscosity radius, KR = 0.0191 nm, and α = 
0.559	  (26). Combining Equations S1-S5, and inserting values for the parameters, ktr can 
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CHAPTER 4 
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There is an increasing interest in formulating new ways of artificial multienzyme 
complexes for more efficient biocatalysis. Inspired by the mechanism of pyruvate 
dehydrogenase complex, we have created multienzyme cascades with cofactor swing 
arms. For connection of enzymes, robust SpyCatcher-SpyTag staple was selected. 
SpyCatcher was genetically fused to C-terminus of S. cerevisiae formate dehydrogenase 
(FDH) to express FDH-SpyCat. Bifunctional PEGs were used to first attach NAD+ to 
PEG, then PEG-NAD+ to FDH-SpyTag. SpyTag peptide was genetically fused to N-
termini of various dehydrogenases (DH), cytosolic malate DH (cMDH), aldehyde 
dehydrogenase (ALDH), and alcohol dehydrogenase (ADH). Firstly, the function of 
FDH-Spy-cMDH-PEG-NAD+ was characterized and its apparent kinetic parameters were 
determined. Compared to FDH-SpyCat with an apparent kcat of 0.44 s-1, the new enzyme 
was found to have a kcat of 0.008 s-1. However, apparent Km,F values for both enzymes 
were not (24 ± 4 mM) affected. In order to show the generality of this approach, FDH-
SpyCat-PEG-NAD+ is being used for development of an immobilized three-enzyme 
system, which will convert formate to methanol under mild conditions, unlike industrial 
catalysts. The approach of this study will be a crucial step to prove the importance of 
protein engineering methods for development of industrially relevant biocatalysts. 
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4.2. Introduction 
 
In Nature, enzymes often form complexes to perform biochemical processes either in 
cascades or by a series of coupled reactions (1). These multienzyme complexes operate 
efficiently so that (i) degradation of the intermediate products can be avoided and (ii) 
mass transfer rates between enzymes can be improved (2, 3). As most of these complexes 
are spatially organized, understanding this organization and the processing of 
intermediates is important.  
 
Nature has evolved various means to control the diffusion of intermediates in cascade 
reactions. One example is the pyruvate dehydrogenase complex, which converts pyruvate 
to acetyl coenzyme A through oxidative decarboxylation (4). This complex is composed 
of three enzymes (E1, E2, and E3), where a lipoamide “swing arm” on E2 enzyme 
channels an acetyl group from E1 enzyme to a free coenzyme A, and is reactivated by E3 
enzyme (5-7). Similar spatial organizations have also been discovered in few other 
multienzyme complexes (8-10). 
 
Mimicking these ways is a great challenge, however, artificial multienzyme complexes 
have been successfully constructed using various strategies (1). Scaffold mediated 
colocalization is one such strategy and this approach simply utilizes nucleic acids or 
proteins/peptides to connect enzymes (11, 12). One recent method of channeling by DNA 
mediated scaffold uses chemical swing arms (3). In this method, DNA double-crossover 
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tiles are used to spatially arrange the orientation of the enzymes of interest. A single-
stranded DNA swing arm with an affinity to NAD(H) is attached to this tile and 
facilitates the electron transfer between two enzymes. Two recent studies show the 
feasibility of the swing arm for the effective transfer/channeling of intermediates (13, 14). 
 
An alternative approach to DNA mediated scaffold for construction of enzyme cascades 
is the utilization of peptides to link two enzymes. A robust candidate that has been 
developed by M. Howarth and his collaborators for such purposes is the SpyCatcher-
SpyTag system (15). In these studies, a S. pyogenes protein FbaB has been determined to 
contain a domain, when split into to parts, that leads to two different proteins, a short 
peptide called SpyTag and its partner SpyCatcher. These two proteins form an amide 
bond in a short period of time with high yields. This reaction has also been shown to take 
place in various conditions, and individual parts can be fused to other proteins (15, 16). 
Therefore, it is a very robust system that can be used to position two enzymes close 
enough to form a cascade and to enable the intermediate channeling. An improvement to 
channeling is plausible if cofactors are tethered to SpyCatcher using diverse chemical 
crosslinking techniques. 
 
In a recent study, we have systematically studied the effect of PEGylation of cofactors 
(PEG-NAD(H)) on catalytic performance of two different redox enzymes, S. cerevisiae 
formate dehydrogenase (FDH), and E. coli NAD(H)-dependent D-lactate dehydrogenase 
(nLDH). Upon thorough kinetic analysis, we discovered that changing the cofactor 
	   93	  
molecular weight (PEG-NAD+) did not significantly affect the catalytic turnover number 
(kcat) of FDH. In addition, the catalytic efficiency (k1k3/k2) of this enzyme was calculated 
using the steady-state on- and off-rate constants and it was found that the catalytic 
efficiency with PEGylated cofactors is 40-50% of that with unmodified cofactor (17). 
 
In this work, we have created functional artificial multienzyme complexes by bringing 
two redox enzymes in close proximity with the SpyCatcher-SpyTag system, and further 
modifying these enzymes with tethered PEGylated cofactors (called cofactor swing arms) 
(Figure 4.1(A)). In the first part, we bring FDH-SpyCatcher enzyme with SpyTag-cMDH 
(malate dehydrogenase) and maleimide-PEG-NAD+, and study the functionality of this 
enzyme with activity assays at various substrate concentrations. In the second part, we 
extend the same methodology to combine FDH-SpyCatcher-PEG-NAD+ with other Spy-
tagged dehydrogenases (alcohol dehydrogenase (ADH) and aldehyde dehydrogenase 
(ALDH). Figure 4.1(B)) and aim to show production of methanol from formate without 
adding any additional free cofactor and without requirement of separation of enzyme 
(Figure 4.1(C)). The robust approach suggested in this study will be crucial for the 
development of industrially relevant and inexpensive catalysts that could work under 
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Maleimide and carboxylic acid functionalized methoxyl polyethylene glycol (m.-PEG-
COOH) of molecular weights 3.4 kDa was purchased from Nanocs Inc. (Boston, MA, 
USA). N-hydroxysulfosuccinimide (Sulfo-NHS) was purchased from Thermo Fisher 
Scientific (New York, NY, USA). Amylose resin was purchased from New England 
Biolabs (Ipswich, MA, USA). All other chemicals were purchased from Sigma Aldrich 
(St. Louis, MO, USA) or Thermo Fisher Scientific. 
 
4.3.2. Cloning, Expression, and Purification of Enzymes 
 
Cloning for formate dehydrogenase – Spy catcher (FDH-SpyCat) enzyme was carried out 
in two steps. Firstly, DNA encoding S. cerevisiae formate dehydrogenase (FDH) was 
amplified via PCR using forward primer (with NdeI restriction site underlined) 5’-	  
AAATTTCATATGTCGAAGGGAAAGGTTTTG -3’ and reverse primer (with BamHI 
restriction site underlined) 5’-	   ATATATGGATCCTTTCTTCTGTCCATAAGCTC -3’ 
from FDH-pTrcHis2-Topo vector and cloned into the pET-20b(+) vector (Thermo Fisher 
Scientific). Following this, DNA encoding SpyCatcher was PCR-amplified using forward 
primer (with BamHI restriction site underlined) 5’- 
ATATATGGATCCTCCGGCGCCATG -3’ and reverse primer (with SalI restriction site 
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underlined) 5’- AAATTTGTCGACACCAATATGAGCGTCA -3’ from SpyCatcher-50.1 
vector (which was a kind gift from Prof. David Baker (University of Washington)) and 
cloned into FDH-pET-20b(+) vector. Colonies harboring the desired plasmid were 
transformed into E.coli BL21(DE3) expression cells. For expression, 10 ml of overnight 
culture was added into 1 L Terrific Broth (TB) media that includes 100 µg/ml ampicillin 
and cells were grown until OD600 reached ~0.6. Following induction with 0.5 mM 
isopropyl-β-D-1-thiogalactopyranoside (IPTG), cells were grown at 25 °C for 14-18 h. 
Cells were centrifuged at 4 °C at 6000 rpm for 8 minutes. For purification, cell pellets 
were suspended in a buffer with 20 mM Tris-HCl (pH 7.4), 200 mM NaCl, and 20 mM 
imidazole. HaltTM Protease Inhibitor Cocktail was also added. After sonication, the 
solution was cleared by centrifugation and the supernatant was applied to HisTrap 
columns (GE Healthcare, Piscataway, NJ, USA). Elution was performed with 75-500 
mM imidazole in 20 mM Tris-HCl (pH 7.4), and 200 mM NaCl. Fractions were run on 
SDS-PAGE and those with desired band (56 kDa) were pooled and buffer exchanged into 
20 mM Tris-HCl, pH 7.4. 
 
SpyTag peptide was cloned to N-termini of three different dehydrogenases. Cloning of 
SpyTag-cytosolic malate dehydrogenase (SpyTag-cMDH) to pET-20b(+) vector was 
performed by Dr. Kristen Garcia in a previous study and used as is. Expression and 
purification protocol was the same as FDH-SpyCat; only exception was the elution, 
which was performed with 20-500 mM imidazole in 20 mM Tris-HCl (pH 7.4), and 200 
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mM NaCl. Fractions were run on SDS-PAGE and those with desired band (39 kDa) were 
pooled and buffer exchanged into 20 mM Tris-HCl, pH 7.4.  
 
DNA encoding SpyTag-ALDH (aldehyde dehydrogenease) was PCR amplified with 
forward primer (with restriction site BamHI underlined and DNA encoding SpyTag 
peptide italized) 5’- 
ATATATGGATCCATGGGAGCCCACATCGTGATGGTGGACGCCTACAAGCCGCGA
AGGGTAGTGGTGAAAGTGGTATGCATGGAATGTTGC -3’ and reverse primer (with 
restriction site HindIII underlined) 5’- 
ATATATAAGCTTTTACAATGAGTTCTTCTGAG -3’ and cloned to pMAL-c4e 
vector. Similarly, DNA encoding SpyTag-ADH (alcohol dehydrogenase) was PCR 
amplified with forward primer (with restriction site BamHI underlined and DNA 
encoding SpyTag peptide italized) 5’- ATATATGGATCC 
ATGGGAGCCCACATCGTGATGGTGGACGCCTACAAGCCGACGAAGGGTAGTGGT
GAAAGTGGTATGCATATGAAAGCAG -3’ and reverse primer (with restriction site 
HindIII underlined) 5’- ATATATAAG CTTCTAATCCTCCTTCAATTT -3’ and cloned 
to pMAL-c4e vector. Colonies harboring the desired plasmid were transformed into 
NEB-5α cells. For expression, 10 ml overnight culture were added into 1 L TB media that 
included 100 µg/ml ampicillin and 2 g D-glucose and cells were grown until OD600 
reached ~0.6. Cultures with ADH gene were induced with 0.5 mM IPTG and 0.25 mM 
ZnCl2 and were incubated at 21 °C for 14-18 h. Cultures with ALDH gene were induced 
with 0.5 mM IPTG and were incubated at 19 °C for 40 h (18). Cells were centrifuged at 4 
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°C at 6,000 rpm for 8 minutes. Purification of both enzymes was carried out using the 
same methodology. Cell pellets were resuspended in 20 mM Tris-HCl (pH 7.4), 200 mM 
NaCl, and 1 mM ethylenediaminetetraacetic acid (EDTA). HaltTM Protease Inhibitor 
Cocktail was also added. After sonication, solutions were clarified by centrifugation and 
supernatants were applied to amylose columns (When pMAL-c4e vector is used, 
constructs were expressed with Maltose Binding Protein (MBP) in N-termini. MBP binds 
to amylose). If desired, elution was performed using the buffer with 20 mM Tris-HCl (pH 
7.4), 200 mM NaCl, 1 mM EDTA, and 10 mM maltose. Elutes were run on SDS-PAGE 
for confirmation of purities with desired bands (MBP-SpyTag-ALDH: 100 kDa and 
MBP-SpyTag-ADH: 80 kDa). 
 
4.3.3. Attachment of Maleimide-PEG-COOH to NAD+ 
 
Maleimide-PEG-COOH was coupled to the primary amine group in the adenine moiety 
of NAD+ using N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) 
and sulfo-NHS by following the protocol of the manufacturer (Thermo Fisher Scientific). 
After the coupling reaction, maleimide-PEG-NAD+ was buffer exchanged (at least 3 
times) into 20 mM Tris-HCl (pH 7.4) with centrifugal filter units and immediately used 




	   98	  
4.3.4. Preparation of Multienzyme Complexes 
 
Purified FDH-SpyCat and maleimide-PEG-NAD+ were mixed overnight at 4 °C for 
attachment via cysteine residues on the enzyme (4 of them) and maleimide functional 
group of modified cofactor. Unbound cofactor was washed away with centrifugal units 
and SDS-PAGE was run to confirm the attachment. After, SpyTag-cMDH was mixed 
with FDH-SpyCat-PEG-NAD+ in equimolar amounts and was mixed overnight at 4 °C. 
Unbound SpyTag-cMDH was washed washed away with centrifugal units and the whole 
FDH-Spy-cMDH-PEG-NAD+ was used for activity assays following the confirmation of 
attachment via SDS-PAGE. 
 
For the immobilized three-enzyme system, MBP-SpyTag-ALDH and MBP-SpyTag-
ADH were first applied to the Amylose column. Following this, FDH-SpyCat-PEG-
NAD+ was added to the column to form FDH-Spy-ALDH/ADH-PEG-NAD+. 
 
4.3.5. Kinetic Experiments for FDH-Spy-cMDH-PEG-NAD+ 
 
All kinetic reactions involving FDH-Spy-cMDH-PEG-NAD+ were conducted in 20 mM 
Tris-HCl (pH7.4) buffer at 25 °C by following absorbance of oxaloacetate (OAA) at 250 
nm (OAA absorbs at 250 nm whereas malate does not). In one set of experiments, initial 
sodium formate concentration was saturated at 240 mM and initial OAA concentration 
was verified between 0-100 µM. In another set of experiments, initial OAA concentration 
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was saturated at 100 µM and initial sodium formate concentration was varied between 0-
240 mM. For kinetic assays with FDH-SpyCat, the initial concentration of sodium 
formate varied between 0-240 mM, and that of NAD+ was 1.5 mM. For kinetic assays 
with Spy-cMDH, the initial concentration of OAA was varied between 0-100 µM, and 
that of NADH was 100 µM. Reactions were initiated with the addition of enzyme and run 
for 20 minutes. Experiments were performed in triplicate. The extinction coefficient of 
OAA at 250 nm was calculated as 1.63 mM-1cm-1 and this value was used to convert the 
absorbance data into OAA concentrations. In experiments with individual enzymes, the 
extinction coefficient of NADH at 340 nm was used (6.22 mM-1cm-1) and this value was 
used to convert the absorbance data into NADH concentrations. Initial rates were 
measured for each substrate concentration (saturating cofactor concentrations were used 
to assay individual enzymes, whereas saturating concentrations of OAA or formate were 
used to assay FDH-Spy-cMDH-PEG-NAD+) and these rates were fitted to the Michaelis-
Menten equation (Eqn 1)	   (19) using IgorPro (Wavemetrics Inc., Portland, OR, USA) to 
estimate apparent kinetic parameters. 
𝑣 =    𝑘!"# ∗ [𝑆]𝐾!,! + [𝑆]                                                                                                     (𝐸𝑞𝑛  1) 
v is the initial rate, [S] is the substrate concentration,  kcat is the catalytic turnover rate, 
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4.3.6. Determination of Formaldehyde and Methanol Concentrations 
 
Concentration of formaldehyde and methanol that flows out of Amylose column 
immobilized with FDH-Spy-ALDH/ADH-PEG-NAD+ (due to the conversion of formate 
to formaldehyde and then formaldehyde to methanol) was calculated using previously 
published colorimetric assays (20-22). Briefly, formaldehyde amount in the solution was 
firstly estimated using 3-Methyl-2-benzothiazolinone hydrazone (MBTH) assay. In this 
assay, formaldehyde is converted to a cyanine-colored product in acidic medium and this 
product has an absorbance at 670 nm (22). After determination of formaldehyde in the 
sample, it is treated with alcohol oxidase (from P. pastoris, Sigma Aldrich), which 
converts methanol to formaldehyde. The increase in absorbance at 670 nm is estimated 
via MBTH assay, and the difference in the amounts corresponds to the concentration of 
methanol. 
 
4.4. Results and Discussion 
 
Genes encoding FDH-SpyCatcher and SpyTag-cMDH were PCR amplified, expressed in 
E. coli, and purified using Nickel affinity chromatography. SDS-PAGE analysis of the 
purified enzymes is shown in Figure 4.2 (columns 2 and 3). Purified enzymes were mixed 
in equimolar amounts in order to show the formation of FDH-Spy-cMDH multienzyme. 
The band in column 4 of Figure 4.2 has an approximate molecular weight of 95 kDa, 
which is the sum of sizes of individual enzymes (FDH-SpyCat is 56 kDa and SpyTag-
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cMDH is 39 kDa). This is due to the amide bond formed between SpyCatcher and its 
partner SpyTag (15), and thereby leads to the assembly of FDH-Spy-cMDH multienzyme 
complex. 
 
In order to show that the formation of multienzyme complex does not affect the activity 
of individual enzymes, an experiment, which utilizes the absorbance of NADH at 340 
nm, was designed. In this experiment, starting mixture contains formate and freely 
diffusing NAD+ (both are substrates of FDH). Upon the addition of FDH-Spy-cMDH, the 
reaction is initiated as could be followed by the increase in absorbance at 340 nm (or 
formation of NADH, Figure 4.3). Approximately at 400 seconds, varying amounts of 
oxaloacetate (OAA) were added to the mixture (substrate of cMDH), leading to a sudden 
decrease in NADH concentration due to the reaction between NADH and OAA. This 
shows the activity of cMDH in the cascade is conserved. Following the sudden decrease 
in absorbance, the amount of NADH stayed constant depending for certain duration (due 
to the difference in the amount of OAA added). In this period, NAD(H) was oxidized and 
reduced continuously because of the actions of individual enzymes, until all OAA was 
consumed. Then, concentration of NADH kept increasing as the formate concentration in 
the mixture was in excess amount. Control reactions did not yield the same behavior, 
proving the unique behavior of FDH-Spy-cMDH multienzyme. 
 
The next step involves the tethering of NAD+ to the multienzyme complex. In a recent 
study, we showed that the PEGylation of cofactors leads to different outcomes for 
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different redox enzymes, and PEGylated NAD+ does not significantly affect the turnover 
number or the catalytic efficiency of FDH (17). In a further attempt to covalently bind the 
cofactor to our FDH-Spy-cMDH cascade, we used a bifunctional PEG with maleimide 
and carboxylic acid end groups. EDC-NHS chemistry was utilized to attach PEG to 
NAD+ and maleimide-sulfur (of cysteine amino acid) interaction was used to tether 
modified cofactor to the enzyme. In order to control the place of attachment, modified 
cofactor was mixed with FDH-SpyCat first (which contains 4 Cys residues, all in FDH 
enzyme), and excess maleimide-PEG-NAD+ was filtered out (Figure 4.2, Column 5). 
This sample also contained unattached FDH-SpyCat at 56 kDa, but this could not be 
separated from FDH-SpyCat-PEG-NAD+. Finally SpyTag-cMDH was introduced to this 
enzyme-cofactor complex, resulting in the final form of the cascade, FDH-Spy-cMDH-
PEG-NAD+ (Figure 4.2, Column 6). Similarly, this sample contained some FDH-Spy-
cMDH with unattached PEG-NAD+ (at 95 kDa), which could not be separated from the 
mixture.  
 
The activity of this final complex was followed using absorbance of OAA at 250 nm 
(OAA absorbs at 250 nm whereas malate does not). Change in absorbance from NAD+ to 
NADH at 250 nm is small when compared to OAA to malate (9), therefore the decrease 
in absorbance at 250 nm is indicative of the activity of the whole complex. Figure 4.4 
demonstrates the activity of the whole complex. Only in the presence of whole enzyme 
and both substrates (formate and OAA), a decrease in the absorbance was observed, 
proving the attached PEG-NAD+ moves between two enzymes (therefore acts as a swing 
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arm), being reduced and oxidized continuously until the system reaches a thermodynamic 
equilibrium after approximately 1600 seconds. In addition, when the concentration of the 
whole enzyme was increased, rate of consumption of OAA increased, further proving the 
functionality of the whole enzyme (Figure 4.5). 
 
In order to fully characterize this multienzyme complex, activity assays at saturating 
OAA or saturating formate were conducted and the initial rate data were fitted into 
Equation 1 to obtain apparent Km and kcat. To be able to compare these to individual 
enzymes, activity assays at saturating NAD+ (for FDH-SpyCat) and saturating NADH 
(for SpyTag-cMDH) were conducted. All kinetic data are tabulated in Tables 4.1 and 4.2. 
From Table 4.1, it can be observed that when formate was used as the varying substrate, 
kcat decreased from 0.44 s-1 for FDH-SpyCat to 0.008 s-1 for FDH-Spy-cMDH-PEG-
NAD+. However, Km,F was not affected, and stayed at 24 mM. When OAA was used as 
the substrate, a similar pattern was observed in kcat, a decrease from 160 s-1 for free 
SpyTag-cMDH to 0.002 s-1 for the whole complex. Km,OAA seemed to decrease from 200 
to 34 µM, however, when the large error in SpyTag-cMDH is noted, two Km values might 
be considered to be in the similar range. (As a future work, the kinetic experiments with 
Spy-cMDH will be repeated to obtain a better fit for the apparent kinetic parameters and 
for a better comparison with the whole enzyme.) Overall, it might be concluded that even 
though the catalytic turnover rates of both enzymes were considerably reduced when they 
are part of the bigger multienzyme-cofactor complex, the Km values for either substrates 
were left unaffected, which is practical for an industrial-use point of view.  
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In other words, this new multienzyme complex can convert the substrates to the desired 
products without any requirement of additional cofactor and without any big change in 
affinity to the substrates under mild conditions. Additionally, use of formate 
dehydrogenase is practical as its substrate formate is cheap and the product CO2 is not 
accumulated in the system, making the separation process easier. Huge decrease in 
catalytic turnover rates seems disadvantageous, but can be compensated by increasing the 
amount of this biocatalyst in the mixure or bioreactor.  
 
Having proved the functionality of this methodology, and in order to show the generality 
of the approach, we have cloned the SpyTag to N-terminus of two other enzymes, alcohol 
dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH). These two enzymes were 
cloned into pMAL vector, so upon expression, MBP-Spy-ADH and MBP-Spy-ALDH 
enzymes were translated, and amylose columns were used for purification (Figure 4.6, 
columns 2 and 3). In order to confirm the interaction of SpyTag and SpyCatcher, 
previously purified FDH-SpyCat was mixed with each enzyme separately (Figure 4.6, 
columns 4 and 5) or with both enzymes at the same time (Figure 4.6, column 6); and in 
all cases, formation of FDH-Spy-ADH/ALDH multienzyme complexes was verified. 
 
For future work, the functionality of this three-enzyme system will be investigated. As 
the first step, MBP-Spy-ADH and MBP-Spy-ALDH will be immobilized to the amylose 
column. Then, FDH-SpyCat-PEG-NAD+ will be added to the column, therefore 
	   105	  
immobilizing the whole FDH-Spy-ADH/ALDH-PEG-NAD+ complex to the column. 
This way, it will be possible to feed only formate to the column and produce methanol 
from the outlet (formate to formaldyhde and formaldehyde to methanol). Methanol 
production will be assayed using colorimetric assays (20-22). Hence, by using an 
immobilized and self-contained (i.e. no addition of free cofactor) biocatalyst, it will be 
possible to convert formate to methanol under mild conditions. This will be a more 
advantageous process compared to industrial catalysts used for the same purpose (23, 24), 
and will demonstrate that protein engineering is a key discipline which may be utilized 




As a way of mimicking naturally evolved swing-arm mechanism of pyruvate 
dehydrogenase complex, we have created multienzyme complexes with tethered 
cofactors acting as swinging arms. For this purpose, the robust staple of SpyCatcher-
SpyTag was utilized. FDH-SpyCatcher enzyme was used as a fusion protein, SpyTag 
peptide was utilized with various dehydrogenases (cMDH, ALDH, and ADH), and NAD+ 
was tethered to various FDH-Spy-DH complexes via bifunctional PEGs. FDH-Spy-
cMDH-PEG-NAD+ complex was shown to be active, which means that attached cofactor 
acts as a swing-arm. In addition, Michaelis constants for both substrates were found to be 
unaffected when compared to individual enzymes, although there is a decrease in the 
catalytic turnover rate. Generality of this approach is in development, where an 
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immobilized multienzymatic cascade of FDH-Spy-ALDH/ADH-PEG-NAD+ is expected 
to catalyze formate to methanol under mild conditions. The methodology used in this 
work will be a crucial step for development of self-contained enzyme-cofactor complexes 
and a showcase to demonstrate the importance of integrated use of protein engineering 
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Figure 4.1. Schematic of experiments in this study. (A) Maleimide and carboxylic acid 
modified PEG was first chemically tethered to NAD+ using EDC-NHS chemistry. This 
product was then attached to FDH-SpyCatcher via maleimide-Cys interaction. (B) 
Various (malate, alcohol, and aldehyde) dehydrogenases (DHs) were added to this 
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protein to obtain the multienzyme complexes FDH-Spy-other DHs-PEG-NAD+. (C) 
FDH-Spy-ALDH/ADH-PEG-NAD+ construct was immobilized to amylose column via 
maltose binding protein (MBP) and used for conversion of formate to methanol. 
 
 
Figure 4.2. SDS-PAGE gel for the constructs that were used in the first part of this study. 
Column (1) Protein standard, (2) FDH-SpyCatcher (56 kDa) after purification, (3) 
SpyTag-cMDH (39 kDa) after purification, (4) Equimolar mixture of FDH-SpyCatcher 
and SpyTag-cMDH leading to FDH-Spy-cMDH multienzyme (95 kDa), (5) Mixture of 
FDH-SpyCatcher (56 kDa) and FDH-SpyCatcher-PEG-NAD+ (band above 56 kDa), (6) 
Mixture of FDH-SpyCatcher-PEG-NAD+ with SpyTag-cMDH to yield the final complex 
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FDH-Spy-cMDH-PEG-NAD+ (note that certain amount of FDH-Spy-cMDH 
multienzyme at 95 kDa could not be separated). 
 
 
Figure 4.3. Confirmation of activity for FDH-Spy-cMDH multienyme. Starting mixture 
contains 0.5 mM NAD+, 19 mM formate and 25 µM FDH-Spy-cMDH. At 400 s, 0.1 or 
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Figure 4.4. Activity assay for FDH-Spy-cMDH-PEG-NAD+ (labeled as ‘Enzyme’ in the 
legend). Reaction mixtures contain 5 mM formate, 0.2 mM oxaloacetate (OAA), and 20 
µM enzyme. Reactions were started with the addition of formate, and absorbance of OAA 
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Figure 4.5. Consumption of OAA as a function of enzyme (FDH-Spy-cMDH-PEG-
NAD+) concentration. Starting mixtures contain 5 mM formate, 0.5 mM OAA, and 5-40 
µM enzyme. Reactions were started with the addition of formate, and absorbance of OAA 











Figure 4.6. SDS-PAGE gel for second part of this study. Column (1) FDH-SpyCat (56 
kDa), (2) MBP-Spy-ADH (80 kDa), (3) MBP-Spy-ALDH (110 kDa), (4) Mixture of 
FDH-SpyCat and MBP-Spy-ADH, (5) Mixture of FDH-SpyCat and MBP-Spy-ALDH, 
(6) Mixture of all three enzymes. 
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Table 4.1. Apparent kinetic constants of FDH-Spy-cMDH-PEG-NAD+ when 
oxaloacetate (OAA) was used as the saturating substrate. This was compared to wild type 
FDH-SpyCat with NAD+ as the saturating substrate.  
Enzyme Km,F (mM) kcat (s-1) Saturated Substrate 
FDH-SpyCat 24 ± 4 0.44 ± 0.02 NAD+ 
FDH-Spy-cMDH-PEG-NAD+ 24 ± 4 0.008 ± 0.0003 OAA 
 
Table 4.2. Apparent kinetic constants of FDH-Spy-cMDH-PEG-NAD+ when formate 
was used as the saturating substrate. This was compared to wild type SpyTag-cMDH with 
NADH as the saturating substrate.  
Enzyme Km,OAA (µM) kcat (s-1) Saturated Substrate 
SpyTag-cMDH 200 ± 300 160 ± 190 NADH 
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CHAPTER 5 
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A version of this chapter is in preparation for publication with co-authors Scott Banta 




As a way of developing new strategies for creating multiprotein complexes, DNA and 
protein/peptide based linkers have increasingly been utilized over the last decade. 
Sequences of heterotrimer collagen mimetic peptides were also developed recently, 
however it has not been used to create multiprotein scaffolds. Hartgerink and his 
colleagues have recently developed Hydroxyproline-free heterotrimer (ABC type) 
sequences with a reported melting temperature of 37 °C. We have cloned the sequence of 
C strand to N-terminus of E. coli NAD(H)-dependent D-lactate dehydrogenase (nLDH), 
expressed and purified. Collagen B was expressed with green fluorescent protein (GFP) 
whereas Collagen A was chemically synthesized. Various experimental conditions were 
tested in order to find the optimum temperature for GFP-Collagen-nLDH complex, and 
based on circular dichroism (CD) experiments 55 °C was selected as the maximum 
temperature for heating of individual enzymes. Various collagen mixtures were analyzed 
at analytical size exclusion column in order to determine the formation of a high-
molecular-weight complex. Although, the results might suggest formation of a GFP-
Collagen-nLDH multiprotein, further experiments are required to verify it. Future studies, 
which involve modification of collagen sequences, will be helpful for development of 
novel artificial multienzyme complexes with improved electron transfer rates. 
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5.2. Introduction 
 
In Nature, enzymes often form complexes to perform biochemical processes either in 
cascades or by a series of coupled reactions (1). As most of these complexes are spatially 
organized, understanding this organization and the self-assembly of these complexes are 
important. Mimicking these ways is a crucial challenge, however, artificial multienzyme 
complexes have been successfully constructed using various strategies (2). Some of these 
strategies are: (i) gene fusion of different enzymes (3), (ii) co-immobilization of enzymes 
on solid supports (4), (iii) co-entrapment of enzymes in polymersomes (5), and (iv) 
scaffold-mediated colocalization. Scaffold mediated assemblies utilize nucleic acids or 
proteins/peptide (6, 7). The approach is simply to connect enzymes by attaching them to 
nucleic acids or peptide/protein linkers (2, 8). 
 
Collagen mimetic peptides are possible examples that could be utilized for such purpose 
of creating multienzyme complexes. Collagen is one of the most commonly found 
proteins in the human body, and comprise of various subcategories based on its structure 
(9-12). Collagen formation includes multiple steps (10, 11), but its most basic form is a 
triple helix, with each strand having amino acid repeats of Gly-Xaa-Yaa, where Xaa is 
usually Pro (P, proline) and Yaa is usually Hyp (O, 4R-hydroxyproline). They can also be 
homotrimers (AAA) or heterotrimers (AAB, ABC, etc.) (10). 
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There have been numerous rational and computational approaches to design and 
synthesize sequences of ABC type collagen mimetic peptides (13-21). These sequences 
are designed such that individual strands can be covalently formed (15, 22-23), or 
electrostatic interactions among sequences can be utilized for self-assembly. When 
designing sequences for the latter case, specificity and stability of the final ABC 
heterotrimer are two important criteria that need to be taken into consideration. 
Specificity refers to the preference of target state of ABC over other competing states of 
AAA, AAB, CAB and so forth, whereas stability is related to the point of thermal 
denaturation (or simply melting temperature) of the ABC heterotrimer (13). 
 
Recently, J. Hartgerink and his colleagues designed amino acid sequences for 
hydroxyproline-free ABC type heterotrimer, with a reported melting temperature of 37 
°C (24). This design was an important milestone, since decrease in the hydroxyproline 
content is often correlated to a decrease in thermal stability of the collagen helix (25, 26). 
The designed sequences are comprised of (PKG)10 (Collagen A), (DKG)10 (Collagen B), 
and (EPG)10 (Collagen C) and the formation of collagen helix is possible via electrostatic 
interactions between lysine-aspartic acid and lysine-glutamic acid pairs (24). 
 
As a new way of creating artificial multienzyme complexes, we have used these collagen 
sequences to bring two proteins in close proximity. For this purpose, we have cloned the 
sequence of Collagen C to N-terminus of E. coli NAD(H) dependent D-lactate 
dehydrogenase (nLDH) and that of Collagen B to C-terminus of green fluorescent protein 
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(GFP). The peptide with sequence of Collagen A was chemically synthesized. Various 
conditions have been tested to prove the formation of a GFP-Collagen-nLDH complex 
and the results of these efforts are reported in this chapter. 
 




The peptide with the sequence of strand A of collagen heterotrimer used in this study 
(Ref) was synthesized by LifeTein (Somerset, NJ, USA). All chemicals were purchased 
from Sigma Aldrich (St. Louis, MO, USA) or Thermo Fisher Scientific (Waltham, MA, 
USA) unless specified otherwise. 
 
5.3.2. Cloning, Expression, and Purification of Enzymes 
 
Cloning of Collagen C-nLDH (NAD(H)-dependent D-lactate dehydrogenase) was carried 
out in two steps. Firstly, DNA encoding E. coli nLDH was PCR amplified using forward 
primer (with restriction site BamHI underlined) 5’- 
ATATATGGATCCATGAAACTCGCCGTTTATAGC -3’ and reverse primer (with 
restriction site HindIII underlined) 5’- AAATTTAAGCTTAACCAGTTCGTTCGGGC -
3’ and ligated to pET-20b(+). Sequence of Collagen C was amplified using overlap 
extension PCR with forward (5’-  
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GGGAGAGCCCGGTGAACCTGGCGAACCCGGAGAACCAGGCGAGCCCGGAGA
ACCCGGTGGCGGCTCAGGGGGGTCTGGCGGT -3’) and reverse (5’ GCCTGGTTC 
TCCGGGTTCGCCAGGTTCACCGGGCTCTCCCGGCTCCCCTGGTTCTCCTGGCT
CACCAGGCTCCCCGCCACC -3’) ultramers; with forward primer (with restriction site 
NdeI underlined) 5’- ATATATCATATGGGTGGCGGGGAGCCT -3’ and reverse 
primer (with restriction site BamHI underlined) 5’- ATATATATGGATTCACCGCC 
AGACCCCCC -3’ and ligated to nLDH-pET-20b(+) vector. Colonies harboring the 
desired plasmid were transformed into E. coli BL21(DE3) expression cells. For 
expression, 10 ml overnight culture were added into 1 L TB media that included 100 
µg/ml ampicillin, and cells were grown until OD600 reached ~0.6. Following induction 
with 0.5 mM IPTG, cultures were incubated at 37 °C for 14-18 h (27). Cells were 
centrifuged at 4 °C at 6,000 rpm for 8 minutes. For purification, cell pellets were 
resuspended in 50 mM HEPES (pH 8.0), 150 mM NaCl, and 10 mM imidazole. After 
sonication, solutions were clarified by centrifugation and supernatants were applied to 
HisTrap columns (GE Healthcare, Piscataway, NJ, USA). Elution was performed using 
10-250 mM imidazole in 50 mM HEPES (pH 8.0) and 150 mM NaCl. Fractions were run 
on SDS-PAGE and those with desired band (41.8 kDa) were pooled and buffer 
exchanged into 20 mM Tris-HCl, pH 7.4 (for activity assays) or 10 mM sodium 
phosphate (monobasic), pH 7.1 (for other experiments). 
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Other enzymes used in this study, namely green fluorescent protein-Collagen B (GFP-
Collagen B) and FKBP-type peptidyl-prolyl cis-trans isomerase (FKBP), were kind gifts 
from Prof. Ronald Koder (City College of New York). 
 
5.3.3. Circular Dichroism (CD) Experiments  
 
All CD experiments were conducted in Banta Lab using Jasco J815 CD Spectrometer 
(Easton, MD, USA) and temperature/wavelength scan measurements were performed for 
all three enzymes in 10 mM sodium phosphate (monobasic), pH 7.1 buffer. 
Concentration of enzymes was 5 µM, and the scan was conducted from 25 to 95 °C. CD 
was measured at 222 nm for Collagen C-nLDH, and at 217 nm for GFP-Collagen B and 
FKBP. All experiments were duplicated. 
 
5.3.4. Activity Assay of the Individual Enzymes 
 
In order to check the function of the enzymes after heating process (which is required for 
formation of GFP-Collagen-nLDH), individual enzymes were heated up to 95 °C for 15 
min, cooled down and their activities were analyzed. For GFP-Collagen B, its 
fluorescence was checked under UV light. The activity of Collagen C-nLDH was 
checked via absorbance of NADH at 340 nm. The initial concentration of sodium 
pyruvate was 1 mM and that of NADH was 0.28 mM. Reactions were initiated with the 
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addition of enzyme.  The extinction coefficient of NADH (6.22 mM-1 cm-1) at 340 nm 
was used to convert the absorbance data into NADH concentrations. 
 
5.3.5. Preparation of Collagen Assemblies 
 
Equimolar amounts (20 µM) of Collagen A, GFP-Collagen B, and Collagen C-nLDH 
were mixed in 10 mM sodium phosphate (monobasic, pH 7.1) buffer and heated up to 
either 95 °C or 55 °C for 15 minutes. Following, they were left at room temperature, 
continuously rotating, for 3-4 days. 
 
5.3.6. Analysis of Collagen Assemblies 
 
Analysis of various collagen mixtures was performed at Koder Lab (City College of New 
York) using BioSep-SEC-s3000 (Phenomenex Inc., Torrance, CA, USA) column. Prior 
to injection, all samples were purified with syringe filter (GE Healthcare, Chicago, IL, 
USA). Running buffer was 10 mM sodium phosphate (monobasic, pH 7.1) and flow rate 
was 0.75 ml/min. Absorption was measured at 280 and 395 nm (395 nm was selected for 
confirmation of GFP presence) for 20 min. In addition, Bio-Rad (Hercules, CA, USA) gel 
filtration standard (dissolved in running buffer) was run in order to construct a standard 
curve that correlates the molecular weight to retention time. Data from the standard 
sample were fitted using IgorPro (Wavemetrics Inc., Portland, OR, USA), and following 
empirical equation was estimated:  
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𝑆𝑖𝑧𝑒   𝑘𝐷𝑎 = 20.7+ 649 ∗ 𝑒!!.!"∗ !"#$ !"# !!.!                             (𝐸𝑞𝑛  1) 
This equation was used to estimate the molecular weight of the peaks of samples with 
various collagen mixtures.  
 
5.4. Results and Discussion 
 
Genes encoding Collagen C-nLDH were PCR amplified, expressed in E. coli, and 
purified by immobilized metal affinity chromatography. GFP-Collagen B and FKBP 
were kind gifts by Prof. Ronald Koder. Their purities were checked with SDS-PAGE 
before use.  
 
In literature, various methods and experimental conditions were tested to confirm 
formation of designed collagen mimetic peptides (13-24). Most of these conditions were 
selected and optimized to show presence of collagen heterotrimer, which are composed 
of free collagen strands. The first step of the protocol involves mixing and heating of 
individual strands up to higher temperatures (up to 95 °C) and let them unfold for a short 
amount of time (10-15 min), then cool the mixtures down to room temperature or 4-5 °C 
to let them anneal over 48-72 hr (24). Since collagen mimetic peptides were not used as a 
scaffold to bring proteins into close proximity before (to our best knowledge), the initial 
conditions tested for our enzyme-collagen complexes involved heating the mixtures of A, 
B, and C complexes to 95 °C for 15 minutes, and then letting them cool at room 
temperature for 3 days. However, this lead to precipitation of samples containing 
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Collagen C-nLDH and/or GFP-Collagen B. Despite this, these samples were filtered and 
analyzed via analytical size exclusion column (SEC), but the resulting SEC profiles (not 
shown) were inconclusive. 
 
In order to find the maximum temperature these proteins can handle before unfolding 
and/or losing their structures, circular dichroism (CD) experiments were conducted as a 
function of time. Depending on the structure of the protein of interest, a wavelength is 
selected and the temperature is increased between 25 and 95 °C, and the ellipticity is 
recorded as a function of time. When there is an increase in this ellipticity, the protein 
starts to lose its secondary structure (28). Based on the available structures, Collagen C- 
nLDH is mainly composed of alpha-helices (so the scan was conducted at 222 nm), 
whereas GFP-Collagen B and FKBP are mainly composed of beta-sheets (217 nm used 
as the wavelength). Figure 5.1 shows the results of such efforts; and among the three 
proteins analyzed, the ellipticity value started to increase at approximately 50 °C for 
Collagen C-nLDH, before the other two proteins (Figure 5.1(A)).  
 
In addition to CD analysis, the activities of Collagen C-nLDH and GFP-Collagen B were 
analyzed individually. For this purpose, each enzyme was heated up to various 
temperatures for 15 minutes and used for activity assay after cooling down. Heating to 95 
°C lead to loss of activity of Collagen C-nLDH (Figure 5.2, triangles) and GFP-Collagen 
B lost its fluorescence. Collagen C-nLDH could preserve some activity up to 55 °C 
(Figure 5.2, squares) and similarly GFP-Collagen B had fluorescence under UV light. 
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Based on CD results and analysis of activities, we decided that 55 °C would be the 
maximum temperature we could use for the heating process of collagen mixtures. 
 
After running the gel filtration standard in the reaction buffer, a standard curve was 
constructed using Equation 1 (Figure S5.1), and this was used to estimate the molecular 
weight of the peaks for the collagen mixtures. For analysis, two wavelengths were 
selected, 280 nm for determining any protein content, and 395 nm for determining any 
GFP content. Using Equation 1, sizes of the major peaks were determined, and intensity 
values at 395 nm corresponding to these peaks were tabulated at Table 5.1.  
 
In order to determine the peaks for the individual enzymes, GFP-Collagen B (Figure 
5.3(A)) and Collagen C-nLDH (Figure 5.3(B)) were run prior to the experiments 
involving any mixture of them. GFP-Collagen B yields two major peaks, one 
corresponding to approximately 30 kDa (corresponding to the size of the protein), and 
another one, which is approximately 2 kDa. The latter peak has an absorbance value 
higher than the former one, and did not appear in any other samples. Since its identity 
could not be determined, as a part of future work, this sample will be run again. 
Originally, Collagen C-nLDH was not expected to result in a peak at 395 nm (in addition, 
AU values at 280 nm were observably higher than those at 395 nm), but two peaks 
showed up, with approximate sizes of 980 kDa and 41 kDa. The latter peak might 
correspond to monomer of Collagen C-nLDH (41.8 kDa). Further experiments are 
required to determine what the size of the former peak corresponds to. As part of the 
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controls, a combination of GFP-Collagen B and Collagen C-nLDH was also run (Figure 
5.3(C)). Three major peaks were observed at 395 nm, the first two of which correspond to 
similar molecular weights and AU values of Collagen C-nLDH. The size of the last one is 
approximately 30 kDa, suggesting this was GFP-Collagen B.  
 
Figure 5.3(D) shows the results when Collagen A, GFP-Collagen B and Collagen C-
nLDH were mixed. Peaks were observed at similar molecular weights as the B+C 
sample. However, when AU values were compared, there is a considerable decrease in all 
the values, which might mean that the constructs containing B and C strands could form a 
complex with a higher molecular weight upon addition of Collagen A. Such a complex 
might be the desired GFP-Collagen-nLDH, however it did not show in the spectra. To 
further improve the formation of a collagen mimetic peptide, FKBP protein, which 
contains prolyl isomerase, was added as well. One of the functions of prolyl isomerase is 
to catalyze the cis-trans isomerization of Pro residues during protein folding (29), 
therefore addition of FKBP might be advantageous for the formation of GFP-Collagen-
nLDH complex. Upon analysis of the sample with all four peptides/proteins, the spectra 
at 395 nm resulted in two major peaks (Figure 5.3(E)). These peaks have AU values that 
are similar to the last two peaks of the A+B+C sample, and the first peak that showed up 
in A+B+C spectra completely disappeared. It is possible that the addition of FKBP might 
have resulted in higher amounts of collagen multiprotein complex, however, since such a 
complex did not show up in the spectra, more samples should be analyzed before making 
further speculation. 
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For future work, there are few options to follow. Firstly, all of the samples will be 
analyzed at analytical SEC in order to confirm the values and retention of the 
aforementioned peaks. For a clearer picture (especially for peaks with earlier retention 
times), a concentration value higher than 20 µM can be picked as well. One alternative is 
to filter the collagen mixtures before heating it up, instead of filtering before injection to 
SEC column. It is possible that such a big complex as GFP-Collagen-nLDH might have 
formed, yet filtered out prior to injection, and not showed up in the absorption spectra. 
One final experiment to prove formation of a collagen complex is to utilize a chemical 
crosslinker (such as glutaraldehyde) for fixation of any possible multiprotein complex 




As a way of mimicking Nature’s way of creating multienzyme complexes, there is an 
increasing amount of research that utilizes various strategies. One way to form such 
assemblies is the utilization of protein/peptide linker-based systems to bring 
enzymes/proteins into close proximity. In this study, we have investigated the possibility 
of using collagen mimetic peptides to create a multiprotein complex. For this purpose, a 
recently published collagen heterotrimer was utilized and two of individual strands were 
genetically fused to two different proteins, GFP and nLDH. CD experiments were 
conducted to find the optimum conditions for the experimental procedure, and 55 °C was 
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found to be the maximum temperature suitable for collagen formation reactions. Various 
mixtures were analyzed with analytical SEC column, and the results of those experiments 
suggest there might be a possible formation of a higher molecular weight complex of 
GFP-Collagen-nLDH, however, further experiments need to be conducted to verify such 
a multiprotein complex. Upon confirmation of the complex, this will be the first time that 
a collagen mimetic peptide could be used as a staple. Possibility of modification of 
collagen sequences will create a path towards artificial multienzyme complexes with 
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5.6. Figures and Tables 
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Figure 5.1. CD spectra data as a function of temperature for the proteins used in this 
study. (A) Collagen C-nLDH spectra was measured at 222 nm, (B) GFP-Collagen B and 
(C) FKBP spectra were measured at 217 nm. All enzyme concentrations were 5 µM.  
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Figure 5.2. Activity assay of Collagen C-nLDH. Initial concentration of sodium pyruvate 
was 1 mM and that of NADH was 0.28 mM. Absorbance of NADH at 340 nm was 
measured as a function of time after the addition of enzyme, and these values were 
converted to NADH concentration using its molar extinction coefficient. The samples 
were heated up to 95 °C for 15 min, cooled down and their activities were analyzed. 
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Figure 5.3. Analytical SEC results for collagen mixes at 395 nm. Ordinate shows the 
intensity value (in mAU) whereas abscissa shows the retention time (in min). (A) GFP-
Collagen B, (B) Collagen C-nLDH, (C) Equimolar mixture of GFP-Collagen B and 
Collagen C-nLDH, (D) Equimolar mixture of Collagen A, GFP-Collagen B and Collagen 
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Table 5.1. Intensity values of the peaks at various retention times for collagen mixtures 
used in this study at 395 nm. 
 
Sample Intensity (mAU) at 8.2 min (980 kDa) 
Intensity (mAU) at 
10.2 min (41 kDa) 
Intensity (mAU) at 
14.4 min (30 kDa) 
GFP-B - - 10974 
C-nLDH 748 1150 - 
GFP-B+C-nLDH 328 905 19245 
A+GFP-B+C-nLDH 29 615 8685 
A+GFP-B+ 
















	   139	  
5.7. Supplementary Information 
 
 
Figure S5.1. Standard curve for analytical SEC column. Bio-Rad gel filtration standard 
was dissolved in running buffer, and injected to column. The size of protein versus 
retention time data was fitted to Equation 1 in order estimate the size of various collagen 
mixtures.  
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Figure S5.2. Analytical SEC results for collagen mixes at 280 nm. Ordinate shows the 
intensity value (in mAU) whereas abscissa shows the retention time (in min). (A) GFP-
Collagen B, (B) Collagen C-nLDH, (C) Equimolar mixture of GFP-Collagen B and 
Collagen C-nLDH, (D) Equimolar mixture of Collagen A, GFP-Collagen B and Collagen 
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CHAPTER 6 
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6.1. Summary of the Thesis Work 
 
In this Thesis, the electron transfer mechanisms of oxidoreductases were utilized for 
various applications in biocatalysis. As multistep/engineered approaches are becoming 
more practical in biocatalysis (1), integration of protein engineering with other fields 
have become more crucial (2), with few ideas yielding more effective outcomes. 
Integration of biocatalysts with (nano)devices, and use of protein based scaffolds to 
create novel multienzyme complexes are such two ideas that have been used in this work 
(1). 
 
In Chapter 2, a cytochrome P450 enzyme, CYP27B1, was used for developing a 
biosensor to detect vitamin D levels. Inspired by the electron transfer mechanism of this 
class of enzymes, we have used this specific enzyme in combination with an artificial 
redox mediator and immobilized on an electrode surface. Enzyme modified electrode was 
found to be sensitive to 25(OH)D (most circulating form of vitamin D) in the 
physiological range. This study is a proof-of-concept that shows the possibility of a 
vitamin D biosensor, which would diminish the time and cost necessary for testing 
vitamin D levels (3). 
 
In Chapter 3, we systematically studied the effect of PEGylation of cofactors on 
biocatalysis, by also looking at the interplay between mass transfer and catalysis. The 
impact of PEGylation was investigated for two redox enzymes, by running kinetic 
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experiments with cofactors of different molecular weights. Detailed kinetic, 
thermodynamic and mass transfer analysis suggested that diffusion of the cofactor to the 
enzyme was not the rate-limiting step, instead the rate of formation of enzyme/cofactor 
and/or enzyme/cofactor/substrate complexes was found to be the dominant effect that 
impacted the biocatalysis (4).  
 
Chapter 4 builds on our improved understanding of modified cofactors, and utilized 
PEGylated cofactors as a part of artificial multienzyme complexes. In this study, we 
wired redox enzymes with the SpyCatcher-SpyTag protein (5), and then attached 
PEGylated cofactors. FDH-Spy-cMDH-PEG-NAD+ system was shown to be functional, 
and this proves that tethered cofactor acts as a swing-arm between two enzymes. We then 
applied this approach to other enzymes, where we have created a three-enzyme system 
with its cofactor immobilized to an amylose column via maltose binding protein. 
Ongoing studies are focused on proving the functionality of this system, which in turn is 
expected to be an important biocatalyst with possible industrial applications (6). 
 
In Chapter 5, as a novel way of assembling multiprotein complexes, applicability of a 
collagen mimetic peptide was investigated. Sequences of a published ABC-type collagen 
(7) were utilized by genetically fusing two of the strands to lactate dehydrogenase 
(nLDH) and green fluorescent protein (GFP). Circular dichroism experiments were 
conducted to find the optimum conditions for self-assembly of GFP-Collagen-nLDH 
multiprotein, and 55 °C was found to be the maximum temperature that can be used. 
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Various collagen mixtures were analyzed via size exclusion column, and initial results 
might suggest the formation of such a multiprotein complex. Further experimental 
techniques are ongoing for confirmation of GFP-Collagen-nLDH. 
 
6.2. Future Directions 
 
By using the ideas introduced in Chapter 1 and section 6.1 of this chapter, this Thesis 
shows the importance of integrating protein engineering with other disciplines for 
creating solutions for problems that might be observed in biocatalysis. However, the 
impact of this work might be expanded and increased by implementing various ideas.  
 
The biggest promise of the work in Chapter 2 would be the development of vitamin D 
biosensor. This work demonstrated the proof-of-principle, but there are few more ways to 
improve the enzyme immobilized electrode. For immobilization, human version of 
CYP27B1 was utilized. As this enzyme has important stability issues, site specific 
mutations and directed evolution studies can be followed for improving its stability. This 
would help preserve the activity of the enzyme for longer times, which is a critical feature 
for biosensor development. Alternatively, another version of this enzyme could be used 
as well (8). Another area of the development is the optimization of the electrode 
assembly. This would help operate the sensor in the entire physiological range of 
25(OH)D, and therefore develop a limit of detection curve. Following optimization, the 
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electrode should also be tested with other blood-derived samples, as it is a crucial step to 
figure the impact of interferents. 
 
The analysis in Chapter 3 could be expanded in few different directions. One of the main 
conclusions from this study was there was two different effects on catalysis for two redox 
enzymes. Same PEGylated cofactors might be used with other redox enzymes and based 
on the results; the existence of an overall behavior/trend might be searched among 
dehydrogenases. Similarly, pre-steady state kinetic analysis can be conducted to quantify 
the impact of the PEG group on conformational dynamics of these enzymes. 
 
Future work of Chapter 4 will include the detailed analysis of the immobilized three-
enzyme system under various conditions. Conversion of formate to methanol via this 
multienzyme complex will be investigated using colorimetric assays that detect any 
methanol formation (9-11). Production of methanol will be tested at different initial 
formate concentrations, and the optimum amounts will be determined. This will be an 
advantageous process compared to conventional catalysts, since the biocatalyst works 
under mild conditions. Additionally, the stability of cofactor swing-arms should be 
investigated in order to estimate the lifetime of this biocatalyst. Finally, the length (by 
using shorter/longer PEGs) and the number (by inserting more Cys residues) of cofactor 
swing arms might be altered to see if there are any changes in the efficiency of the 
cascade. 
 





Figure 6.1. Variants of collagen by modification of Collagen A. (A) With current version 
of Collagen A, two proteins can act more efficiently via proximity effect. (B) By 
modifying the sequence with negatively charged amino acids, electrostatic guidance 
could be used for transfer of cofactor, in addition to proximity effect. (C) Non-natural 
amino acids (such as conductive amino acids) might improve the efficiency by directly 
transferring the electron. 
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Figure 6.2. Direct electron transfer between two enzymes via collagen heterotrimer 
peptide. 
 
Chapter 5 could be improved to extend the application of collagen mimetic peptide for 
creating other multienzyme complexes. Once the formation of GFP-Collagen-nLDH 
complex is verified and the experimental conditions for the formation of collagen 
heterotrimer are finalized, individual collagen strands will be used with other enzymes. 
As an initial work, we have cloned Collagen B to C-terminus of formate dehydrogenase 
(FDH). FDH is a larger protein than GFP, so further optimization of the experimental 
conditions might be necessary to improve the formation of such FDH-Collagen-nLDH 
complex. Different variants of the collagen are also possible by modifying the sequence 
of Collagen A (Figure 6.1). Firstly, the sequence can be modified with more negatively 
charged amino acids, and this can electrostatically guide a positively charged cofactor 
from one enzyme to other, and therefore increase the efficiency. Further modification is 
possible with non-natural amino acids (such as conductive amino acids (12, 13)). This 
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could directly transfer electrons between enzymes and might eliminate the requirement of 
cofactors of these enzymes. Here, it will be important to pick the right set of enzymes. 
Both enzymes should have prosthetic groups (i.e. FAD), and the relative redox potentials 
should be arranged in a way that the electron transfer from one enzyme to the other is 
thermodynamically favorable (Figure 6.2) (14-16). Such a conductive multienzyme 
complex is advantageous since the need for an expensive and unstable cofactor will be 
eliminated and this way more efficient synthetic cascades with fast electron transfer rates 
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